В ходе подготовки статей по физиологии для пользователей сайта МедУнивер использованы труды следующих авторов:

1. Alberts В., Johnson A., Lewis J. et al. Molecular Biology of the Cell. New York: Garland Science, 2002.
2. Grillner S. The motor infrastructure: from ion channels to neuronal networks. Nat Rev Neurosci 4:573, 2003.
3. Hodgkin A.L. The Conduction of the Nervous Impulse. Springfield, IL: Charles C Thomas, 1963.
4. Hodgkin A.L., Huxley A.F. Quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (bond) 117:500, 1952.
5. Kleber A.G., Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84:431, 2004.
6. Lu Z. Mechanism of rectification in inward-rectifier K+ channels. Annu Rev Physiol 66:103, 2004.
7. Matthews G.G. Cellular Physiology of Nerve and Muscle. Malden, MA: Blackwell Science, 1998.
8. Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117, 2003.
9. Poliak S., Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 12:968, 2003.
10. Pollard T.D., Earnshaw W.C. Cell Biology. Philadelphia: Elsevier Science, 2002.
11. Ruff R.L. Neurophysiology of the neuromuscular junction: overview. Ann N Y Acad Sci 998:1, 2003.
12. Xu-Friedman M.A., Regehr W.G. Structural contributions to short-term synaptic plasticity. Physiol Rev 84:69, 2004.

1. Berchtold M.W., Brinkmeier Н., Muntener М. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev 80:1215, 2000.
2. Brooks S.V. Current topics for teaching skeletal muscle physiology. Adv Physiol Educ 27:171, 2003.
3. Clausen T. Na+-K+ pump regulation and skeletal muscle contractility. Physiol Rev 83:1269, 2003.
4. Glass D.J. Molecular mechanisms modulating muscle mass. Trends Mol Med 8:344, 2003.
5. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5:87, 2003.
6. Gordon A.M., Homsher E., Regnier M:. Regulation of contraction in striated muscle. Physiol Rev 80:853, 2000.
7. Gordon A.M., Regnier M., Homsher E. Skeletal and cardiac muscle contractile activation: tropomyosin «rocks and rolls». News Physiol Sci 16:49, 2001.
8. Huxley A.F., Gordon A.M. Striation patterns in active and passive shortening of muscle. Nature (Lond) 193:280, 1962.
9. Huxley H.E. A personal view of muscle and motility mechanisms. Annu Rev Physiol 58:1, 1996.
10. Jurkat-Rott K., Lerche H., Lehmann-Horn F. Skeletal muscle channelopathies. J Neurol 249:1493, 2002.
11. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84:649, 2004.
12. Macintosh B.R. Role of calcium sensitivity modulation in skeletal muscle performance. News Physiol Sci 18:222, 2003.
13. Matthews G.G. Cellular Physiology of Nerve and Muscle. Malden, MA: Blackwell Science, 1998.
14. Sieck G.C., Regnier M. Plasticity and energetic demands of contraction in skeletal and cardiac muscle. J Appl Physiol 90:1158, 2001.
15. Stamler J.S., Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 81:209, 2001.
16. Szent-Gyorgyi A.G. Regulation of contraction by calcium binding myosins. Biophys Chem 59:357, 1996.

1. Blaustein М.Р., Lederer W.J. Sodium/calcium exchange: its physiological implications. Physiol Rev 79:763, 1999.
2. Davis M.J., Hill M.A. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79:387, 1999.
3. Harnett K.M., Biancani P. Calcium-dependent and calcium-independent contractions in smooth muscles. Am J Med 115(Suppl 3A):24S, 2003.
4. Horowitz A., Menice C.B., Laporte R., Morgan K.G. Mechanisms of smooth muscle contraction. Physiol Rev 76:967, 1996.
5. Kamm K.E., Stull J.T. Regulation of smooth muscle contractile elements by second messengers. Annu Rev Physiol 51:299, 1989.
6. Kuriyama H., Kitamura K., Itoh T., Inoue R. Physiological features of visceral smooth muscle cells, with special reference to receptors and ion channels. Physiol Rev 78:811, 1998.
7. Lee C.H., Poburko D., Kuo K.H. et al. Ca2+ oscillations, gradients, and homeostasis in vascular smooth muscle. Am J Physiol Heart Circ Physiol 282:H1571, 2002.
8. Rybalkin S.D., Yan C, Bornfeldt K.E., Beavo J.A. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93:280, 2003.
9. Somlyo A.P., Somlyo A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83:1325, 2003.
10. Stephens N.L. Airway smooth muscle. Lung 179:333, 2001.
11. Walker J.S., Wingard C.J., Murphy R.A. Energetics of crossbridge phosphorylation and contraction in vascular smooth muscle. Hypertension 23:1106, 1994.
12. Webb R.C. Smooth muscle contraction and relaxation. Adv Physiol Educ 27:201, 2003.

1. Bers D.M. Cardiac excitation-contraction coupling. Nature 415:198, 2002.
2. Brette F., Orchard C. T-tubule function in mammalian cardiac myocytes. Circ Res 92:1182, 2003.
3. Brutsaert D.L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmi-city. Physiol Rev 83:59, 2003.
4. Clancy C.E., Kass R.S. Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Invest 110:1075, 2002.
5. Fozzard H.A. Cardiac sodium and calcium channels: a history of excitatory currents. Cardiovasc Res 55:1, 2002.
6. Fuchs F., Smith S.H. Calcium, cross-bridges, and the Frank-Starling relationship. News Physiol Sci 16:5, 2001.
7. Guyton A.C. Determination of cardiac output by equating venous return curves with cardiac response curves. Physiol Rev 35:123, 1955.
8. Guyton A.C., Jones C.E., Coleman T.G. Circulatory Physiology: Cardiac Output and Its Regulation, 2nd ed. Philadelphia: WB Saunders, 1973.
9. Herring N., Danson E.J., Paterson D.J. Cholinergic control of heart rate by nitric oxide is site specific. News Physiol Sci 17:202, 2002.
10. Korzick D.H. Regulation of cardiac excitation-contraction coupling: a cellular update. Adv Physiol Educ 27:192, 2003.
11. Olson E.N. A decade of discoveries in cardiac biology. Nat Med 10:467, 2004.
12. Page E., Fozzard H.A., Solaro J.R. Handbook of Physiology, sec 2: The Cardiovascular System, vol. 1: The Heart. New York: Oxford University Press, 2002.
13. Rudy Y. From genome to physiome: integrative models of cardiac excitation. Ann Biomed Eng 28:945, 2000.
14. Sarnoff S.J. Myocardial contractility as described by ventricular function curves. Physiol Rev 35:107, 1955.
15. Starling E.H. The Linacre Lecture on the Law of the Heart. London: Longmans Green, 1918.
16. Sussman M.A., Anversa P. Myocardial aging and senescence: where have the stem cells gone? Annu Rev Physiol 66:29, 2004.
17. Zucker I.H., Schultz H.D., Li Y.F. et al. The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Prog Biophys Mol Biol 84:217, 2004.

1. Blatter L.A., Kockskamper J., Sheehan K.A. et al. Local calcium gradients during excitation-contraction coupling and alter-nans in atrial myocytes. J Physiol 546:19, 2003.
2. Ferrier G.R., Howlett S.E. Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction. Am J Physiol Heart Circ Physiol 280:H1928, 2001.
3. Gentlesk P.J., Markwood T.T., Atwood J.E. Chronotropic incompetence in a young adult: case report and literature review. Chest 125:297, 2004.
4. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345:1473, 2001.
5. Hume J.R., Duan D., Collier M.L. et al. Anion transport in heart. Physiol Rev 80:31, 2000.
6. James T.N. Structure and function of the sinus node, AV node and His bundle of the human heart: part I—structure. Prog Cardiovasc Dis 45:235, 2002.
7. James T.N. Structure and function of the sinus node, AV node and His bundle of the human heart: part II—function. Prog Cardiovasc Dis 45:327, 2003.
8. Kaupp U.B., Seifert R. Molecular diversity of pacemaker ion channels. Annu Rev Physiol 63:235, 2001.
9. Kleber A.G., Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 84:431, 2004.
10. Leclercq C., Hare J.M. Ventricular resynchronization: current state of the art. Circulation 109:296, 2004.
11. Mazgalev T.N., Ho S.Y., Anderson R.H. Anatomic-electrophysiological correlations concerning the pathways for atrioventricular conduction. Circulation 103:2660, 2001.
12. Page E., Fozzard H.A., Solaro J.R. Handbook of Physiology, sec 2: The Cardiovascular System, vol. 1: The Heart. New York: Oxford University Press, 2002.
13. Petrashevskaya N.N., Koch S.E., Bodi I., Schwartz A. Calcium cycling, historic overview and perspectives: role for autonomic nervous system regulation. J Mol Cell Cardiol 34:885, 2002.
14. Priori S.G. Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ Res 94:140, 2004.
15. Roden D.M., Balser J.R., George A.L. Jr., Anderson M.E. Cardiac ion channels. Annu Rev Physiol 64:431, 2002.
16. Schram G., Pourrier M., Melnyk P., Nattel S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 90:939, 2002.
17. Surawicz B. Electrophysiologic Basis of ECG and Cardiac Arrhythmias. Baltimore: Williams & Wilkins, 1995.
18. Waldo A.L. Mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 14 (12 Suppl):S267, 2003.
19. Yasuma F., Hayano J. Respiratory sinus arrhythmia: why does the heartbeat synchronize with respiratory rhythm? Chest 125:683, 2004.

1. Al-Khatib S.M., LaPointe N.M., Kramer J.M., Califf R.M. What clinicians should know about the QT interval. JAMA 289:2120, 2003.
2. Armoundas A.A., Tomaselli G.F., Esperer H.D. Pathophysiological basis and clinical application of T-wave alternans. J Am Coll Cardiol 40:207, 2002.
3. Bigi R., Cortigiani L., Desideri A. Exercise electrocardiography after acute coronary syndromes: still the first testing modality? Clin Cardiol 8:390, 2003.
4. Cheitlin M.D., Armstrong W.F., Aurigemma G.P. et al. ACC/AHA/ASE 2003 Guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 16:1091, 2003.
5. Cohn P.F., Fox K.M., Daly C. Silent myocardial ischemia. Circulation 108:1263, 2003.
6. Falk R.H. Atrial fibrillation. N Engl J Med 344:1067, 2001.
7. Frenneaux M.P. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90:570, 2004.
8. Greenland P., Gaziano J.M. Clinical practice: selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 349:465,2003.
9. Hurst J.W. Current status of clinical electrocardiography with suggestions for the improvement of the interpretive process. Am J Cardiol 92:1072, 2003.
10. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol 62:25, 2000.
11. Lee T.H., Boucher C.A. Clinical practice: noninvasive tests in patients with stable coronary artery disease. N Engl J Med 344:1840, 2001.
12. Lehmann M.H., Morady F. QT interval: metric for cardiac prognosis? Am J Med 115:732, 2003.
13. Levy S. Pharmacologic management of atrial fibrillation: current therapeutic strategies. Am Heart J 141(2 Suppl):S15, 2001.
14. Marban E. ТЬё surprising role of vascular K(ATP) channels in vasospastic angina. J Clin Invest 110:153, 2002.
15. Maron B.J. Sudden death in young athletes. N Engl J Med 349:1064, 2003.
16. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415:219, 2002.
17. Roden D.M. Drug-induced prolongation of the QT interval. N Engl J Med 350:1013, 2004.
18. Swynghedauw B., Baillard C, Milliez P. The long QT interval is not only inherited but is also linked to cardiac hypertrophy. J Mol Med 81:336, 2003.
19. Topol E.J. A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 41(4 Suppl S):S123, 2003.
20. Wang K., Asinger R.W., Marriott H.J. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349:2128, 2003.
21. Yan G.X., Lankipalli R.S., Burke J.F. et al. Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol 42:401, 2003.
22. Zimetbaum P.J., Josephson M.E. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 348:933, 2003.
23. Zipes D.P., Jalife J. Cardiac Electrophysiology, 3rd ed. Philadelphia: WB Saunders, 1999.

1. Al-Khatib S.M., LaPointe N.M., Kramer J.M., Califf R.M. What clinicians should know about the QT interval. JAMA 289:2120, 2003.
2. Armoundas A.A., Tomaselli G.F., Esperer H.D. Pathophysiological basis and clinical application of T-wave alternans. J Am Coll Cardiol 40:207, 2002.
3. Bigi R., Cortigiani L., Desideri A. Exercise electrocardiography after acute coronary syndromes: still the first testing modality? Clin Cardiol 8:390, 2003.
4. Cheitlin M.D., Armstrong W.F., Aurigemma G.P. et al. ACC/AHA/ASE 2003 Guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 16:1091, 2003.
5. Cohn P.F., Fox K.M., Daly C. Silent myocardial ischemia. Circulation 108:1263, 2003.
6. Falk R.H. Atrial fibrillation. N Engl J Med 344:1067, 2001.
7. Frenneaux M.P. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90:570, 2004.
8. Greenland P., Gaziano J.M. Clinical practice: selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N Engl J Med 349:465,2003.
9. Hurst J.W. Current status of clinical electrocardiography with suggestions for the improvement of the interpretive process. Am J Cardiol 92:1072, 2003.
10. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol 62:25, 2000.
11. Lee T.H., Boucher C.A. Clinical practice: noninvasive tests in patients with stable coronary artery disease. N Engl J Med 344:1840, 2001.
12. Lehmann M.H., Morady F. QT interval: metric for cardiac prognosis? Am J Med 115:732, 2003.
13. Levy S. Pharmacologic management of atrial fibrillation: current therapeutic strategies. Am Heart J 141(2 Suppl): S15, 2001.
14. Marban E. The surprising role of vascular K(ATP) channels in vasospastic angina. J Clin Invest 110:153, 2002.
15. Maron B.J. Sudden death in young athletes. N Engl J Med 349:1064, 2003.
16. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415:219, 2002.
17. Roden D.M. Drug-induced prolongation of the QT interval. N Engl J Med 350:1013, 2004.
18. Swynghedauw B., Baillard C, Milliez P. The long QT interval is not only inherited but is also linked to cardiac hypertrophy. J Mol Med 81:336, 2003.
19. Topol E.J. A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 41(4 Suppl S):S 123, 2003.
20. Wang K., Asinger R.W., Marriott H.J. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349:2128, 2003.
21. Yan G.X., Lankipalli R.S., Burke J.F. et al. Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. J Am Coll Cardiol 42:401, 2003.
22. Zimetbaum P.J., Josephson M.E. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 348:933, 2003.
23. Zipes D.P., Jalife J. Cardiac Electrophysiology, 3rd ed. Philadelphia: WB Saunders, 1999.

1. Badeer H.S. Hemodynamics for medical students. Am J Physiol (Adv Physiol Educ) 25:44, 2001.
2. Benetos A., Waeber B., Izzo J., Mitchell G. et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15:1101, 2002.
3. Gimbrone M.A. Jr., Topper J.N., Nagel T. et al. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902:230, 2000.
4. Guyton A.C. Arterial Pressure and Hypertension. Philadelphia: WB Saunders Co, 1980.
5. Guyton A.C., Jones C.E. Central venous pressure: physiological significance and clinical implications. Am Heart J 86:431, 1973.
6. Guyton A.C., Jones C.E., Coleman T.G. Circulatory Physiology: Cardiac Output and Its Regulation. Philadelphia: WB Saunders Co, 1973.
7. Hall J. Integration and regulation of cardiovascular function. Am J Physiol (Adv Physiol Educ) 22:sl74, 1999.
8. Hicks J.W., Badeer H.S. Gravity and the circulation: “open” vs. “closed” systems. Am J Physiol 262:R725-R732, 1992.
9. Jones D.W., Appel L.J., Sheps S.G. et al. Measuring blood pressure accurately: New and persistent challenges. JAMA 289:1027, 2003.
10. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: Aging arteries: a “set up” for vascular disease. Circulation 107:139, 2003.
11. McAlister F.A., Straus S.E. Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ 322:908, 2001.
12. O’Brien E., Asmar R., Beilin L. et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21:821, 2003.
13. Perloff D., Grim C, Flack J. et al. Human blood pressure determination by sphygmomanometry. Circulation 88:2460, 1993.
14. Rothe C.F., Gersting J.M. Cardiovascular interactions: an interactive tutorial and mathematical model. Am J Physiol (Adv Physiol Educ) 26:98, 2002.
15. Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107:2864, 2003.
16. Verdecchia P., Angeli F., Gattobigio R. Clinical usefulness of ambulatory blood pressure monitoring. J Am Soc Nephrol 15 (Suppl 1):S30, 2004.

1. Aukland К., Reed R.K. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73:1, 1993.
2. D’Amico G., Bazzi C. Pathophysiology of proteinuria. Kidney Int 63:809, 2003.
3. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5:261, 2004.
4. Frank P.G., Woodman S.E., Park D.S., Lisanti M.P. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vase Biol 23:1161, 2003.
5. Gashev A.A. Physiologic aspects of lymphatic contractile function: current perspectives. Ann N Y Acad Sci 979:178, 2002.
6. Guyton A.C. Concept of negative interstitial pressure based on pressures in implanted perforated capsules. Circ Res 12:399, 1963.
7. Guyton A.C. Interstitial fluid pressure: II. Pressure-volume curves of interstitial space. Circ Res 16:452, 1965.
8. Guyton A.C., Granger H.J., Taylor A.E. Interstitial fluid pressure. Physiol Rev 51:527, 1971.
9. Guyton A.C., Prather J., Scheel K., McGehee J. Interstitial fluid pressure: IV. Its effect on fluid movement through the capillary wall. Circ Res 19:1022, 1966.
10. Guyton A.C., Scheel K., Murphree D. Interstitial fluid pressure: III. Its effect on resistance to tissue fluid mobility. Circ Res 19:412, 1966.
11. Guyton A.C., Taylor A.E., Granger H.J. Circulatory Physiology II. Dynamics and Control of the Body Fluids. Philadelphia: WB Saunders Co, 1975.
12. Michel C.C., Curry F.E. Microvascular permeability. Physiol Rev 79:703, 1999.
13. Miyasaka M., Tanaka T. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 4:360, 2004.
14. Oliver G. Lymphatic vasculature development. Nat Rev Immunol 4:35, 2004.
15. Rippe B., Rosengren B.I., Carlsson O., Venturoli D. Transendothelial transport: the vesicle controversy. J Vase Res 39:375, 2002.
16. Taylor A.E., Granger D.N. Exchange of macromolecules across the microcirculation. In: Renkin EM, Michel CC (eds): Handbook of Physiology. Sec. 2, Vol. IV. Bethesda: American Physiological Society, 1984, p. 467.

1. Adair Т.Н., Gay W.J., Montani J.P. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol 259:R393, 1990.
2. Campbell W.B., Gauthier K.M. What is new in endothelium-derived hyperpolarizing factors? Curr Opin Nephrol Hyper-tens 11:177, 2002.
3. Chang L., Kaipainen A., Folkman J. Lymphangiogenesis new mechanisms. Ann N Y Acad Sci 979:111, 2002.
4. Cowley A.W. Jr., Mori T., Mattson D., Zou A.P. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284:R1355, 2003.
5. Davis M.J., Hill M.A. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79:387, 1999.
6. Erdos E.G., Marcic B.M. Kinins, receptors, kininases and inhibitors—where did they lead us? Biol Chem 382:43, 2001.
7. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 9:669, 2003.
8. Granger H.J., Guyton A.C. Autoregulation of the total systemic circulation following destruction of the central nervous system in the dog. Circ Res 25:379, 1969.
9. Guyton A.C., Coleman T.G., Granger H.J. Circulation: overall regulation. Annu Rev Physiol 34:13, 1972.
10. Hall J.E., Brands M.W., Henegar J.R. Angiotensin II and longterm arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 10 (Suppl 12):S258, 1999.
11. Harder D.R., Zhang C., Gebremedhin D. Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci 17:27, 2002.
12. Hester R.L., Hammer L.W. Venular-arteriolar communication in the regulation of blood flow. Am J Physiol Regul Integr Comp Physiol 282:R1280, 2002.
13. Iglarz M., Schiffrin E.L. Role of endothelin-1 in hypertension. Curr Hypertens Rep 5:144, 2003.
14. Kerbel R., Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2:727, 2002.
15. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vas-culogenesis for ischemic disease: Part I: angiogenic cytokines. Circulation 109:2487, 2004.
16. Renkin E.M. Control of microcirculation and blood-tissue exchange. In: Renkin E.M., Michel C.C. (eds): Handbook of Physiology, Sec. 2, Vol. IV. Bethesda: American Physiological Society, 1984, p. 627.
17. Rich S., McLaughlin V.V. Endothelin receptor blockers in cardiovascular disease. Circulation 108:2184, 2003.
18. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131, 2002.
19. Schnermann J., Levine D.Z. Paracrine factors in tubuloglome-rular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65:501, 2003.

1. Antunes-Rodrigues J., De Castro М., Elias L.L.K. et al. Neuroendocrine control of body fluid metabolism. Physiol Rev 84: 169, 2004.
2. Cao W.H., Fan W., Morrison S.F. Medullary pathways mediating specific sympathetic responses to activation of dorsomedial hypothalamus. Neuroscience 126:229, 2004.
3. Cowley A.W. Jr., Guyton A.C. Baroreceptor reflex contribution in angiotensin II-induced hypertension. Circulation 50:61, 1974.
4. DiBona G.F. Peripheral and central interactions between the renin-angiotensin system and the renal sympathetic nerves in control of renal function. Ann N Y Acad Sci 940:395, 2001.
5. DiCarlo S.E., Bishop V.S. Central baroreflex resetting as a means of increasing and decreasing sympathetic outflow and arterial pressure. Ann N Y Acad Sci 940:324, 2001.
6. Esler M., Lambert G., Brunner-La Rocca H.P. et al. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand 177:275, 2003.
7. Felder R.B., Francis J., Zhang Z.H. et al. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 284:R259, 2003.
8. Floras J.S. Arterial baroreceptor and cardiopulmonary reflex control of sympathetic outflow in human heart failure. Ann N Y Acad Sci 940:500, 2001.
9. Goldstein D.S., Robertson D., Esler M. et al. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 137:753, 2002.
10. Guyton A.C. Arterial Pressure and Hypertension. Philadelphia: WB Saunders Co, 1980.
11. Hall J.E., Hildebrandt D.A., Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14:103S, 2001.
12. Ketch T., Biaggioni I., Robertson R., Robertson D. Four faces of baroreflex failure: hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation 105:2518, 2002.
13. Krieger E.M., Da Silva G.J., Negrao C.E. Effects of exercise training on baroreflex control of the cardiovascular system. Ann NY Acad Sci 940:338, 2001.
14. Lohmeier T.E., Lohmeier J.R., Warren S. et al. Sustained activation of the central baroreceptor pathway in angiotensin hypertension. Hypertension 39:550, 2002.
15. Lohmeier T.E. The sympathetic nervous system and long-term blood pressure regulation. Am J Hypertens 14:147S, 2001.
16. Malpas S.C. What sets the long-term level of sympathetic nerve activity: is there a role for arterial baroreceptors? Am J Physiol Regul Integr Comp Physiol 286:R1, 2004.
17. Mifflin S.W. What does the brain know about blood pressure? News Physiol Sci 16:266, 2001.
18. Morrison S.F. Differential control of sympathetic outflow. Am J Physiol Regul Integr Comp Physiol 281:R683, 2001.
19. Sved A.F., Ito S., Sved J.C. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 5:262, 2003.
20. Thrasher T.N. Unloading arterial baroreceptors causes neurogenic hypertension. Am J Physiol Regul Integr Comp Physiol 282:R1044, 2002.
21. Zucker I.H., Wang W., Pliquett R.U. et al. The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training. Ann N Y Acad Sci 940:431, 2001.

1. Chobanian A.V., Bakris G.L., Black H.R. et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42:1206, 2003.
2. Cowley A.W. J. Long-term control of arterial blood pressure. Physiol Rev 72:231, 1992.
3. Granger J.P., Alexander B.T., Bennett W.A., Khalil R.A. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 14:178S, 2001.
4. Granger J.P., Alexander B.T. Abnormal pressure-natriuresis in hypertension: role of nitric oxide. Acta Physiol Scand 168:161, 2000.
5. Guyton A.C. Arterial Pressure and Hypertension. Philadelphia: WB Saunders Co, 1980.
6. Guyton А.С. Blood pressure control — special role of the kidneys and body fluids. Science 252:1813, 1991.
7. Guyton A.C., Coleman T.G., Cowley A.W. Jr. et al. Arterial pressure regulation: overriding dominance of the kidneys in longterm regulation and in hypertension. Am J Med 52:584, 1972.
8. Hall J.E. The kidney, hypertension, and obesity. Hypertension 41:625, 2003.
9. Hall J.E., Brands M.W., Henegar J.R. Angiotensin II and longterm arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 10(Suppl 12):S258, 1999.
10. Hall J.E., Guyton A.C., Brands M.W. Pressure-volume regulation in hypertension. Kidney Int Suppl 55:S35, 1996.
11. Hall J.E., Jones D.W., Kuo J.J. et al. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 5:386, 2003.
12. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 104:545, 2001.
13. Manning R.D. Jr., Hu L., Tan D.Y., Meng S. Role of abnormal nitric oxide systems in salt-sensitive hypertension. Am J Hypertens 14:68S, 2001.
14. Oparil S., Zaman M.A., Calhoun D.A. Pathogenesis of hypertension. Ann Intern Med 139:761, 2003.
15. O’Shaughnessy K.M., Karet F.E. Salt handling and hypertension. J Clin Invest 113:1075, 2004.
16. Reckelhoff J.F. Gender differences in the regulation of blood pressure. Hypertension 37:1199, 2001.
17. Rossier B.C. Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension? J Clin Invest 111:947, 2003.

1. Brengelmann G.L. A critical analysis of the view that right atrial pressure determines venous return. J Appl Physiol 94:849, 2003.
2. Gaasch W.H., Zile M.R. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med. 55:373, 2004.
3. Guyton A.C. Determination of cardiac output by equating venous return curves with cardiac response curves. Physiol Rev 35:123, 1955.
4. Guyton A.C. Venous return. In: Hamilton WF (ed): Handbook of Physiology. Sec 2, Vol. 2. Baltimore, Williams & Wilkins, 1963, p. 1099.
5. Guyton A.C., Coleman T.G., Granger H.J. Circulation: overall regulation. Annu Rev Physiol 34:13, 1972.
6. Guyton A.C., Jones C.E., Coleman T.G. Circulatory Physiology: Cardiac Output and Its Regulation. Philadelphia: WB Saunders Co, 1973.
7. Guyton А.С., Lindsey A.W., Kaufmann B.N. Effect of mean circulatory filling pressure and other peripheral circulatory factors on cardiac output. Am J Physiol 180:463-468, 1955.
8. Koch W.J., Lefkowitz R.J., Rockman H.A. Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol 62:237, 2000.
9. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature 415:206, 2002.
10. Rothe C.F. Mean circulatory filling pressure: its meaning and measurement. J Appl Physiol 74:499, 1993.
11. Rothe C.F. Reflex control of veins and vascular capacitance. Physiol Rev 63:1281, 1983.
12. Sarnoff S.J., Berglund E. Ventricular function. 1. Starlings law of the heart, studied by means of simultaneous right and left ventricular function curves in the dog. Circulation 9:706-718,1953.
13. Uemura K., Sugimachi M., Kawada T. et al. A novel framework of circulatory equilibrium. Am J Physiol Heart Circ Physiol 286:H2376, 2004.
14. Vatner S.F., Braunwald E. Cardiovascular control mechanisms in the conscious state. N Engl J Med 293:970, 1975.

1. Andrew Р. Diastolic heart failure demystified. Chest 124:744, 2003.
2. Braunwald E., Zipes D.P., Liby P. A Textbook for Cardiovascular Medicine. 6th Ed. Philadelphia: WB Saunders Co, 2001. Dorn G.W. 2nd, Molkentin J.D. Manipulating cardiac contractility in heart failure: data from mice and men. Circulation 109:150, 2004.
3. Ducas J., Grech E.D. ABC of interventional cardiology. Percutaneous coronary intervention: cardiogenic shock. BMJ 326:1450, 2003.
4. Eikelboom J., White H., Yusuf S. The evolving role of direct thrombin inhibitors in acute coronary syndromes. J Am Coll Cardiol 41 (4 Suppl S):70S, 2003.
5. Floras J.S. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177:391, 2003.
6. Gavras H., Brunner H.R. Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure. Hypertension 37:342, 2001.
7. Gehlbach B.K., Geppert E. The pulmonary manifestations of left heart failure. Chest 125:669, 2004.
8. Guyton A.C., Jones C.E., Coleman T.G. Circulatory Physiology: Cardiac Output and Its Regulation. Philadelphia: WB Saunders Co, 1973.
9. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107:2998, 2003.
10. Lohmeier T.E. Neurohumoral regulation of arterial pressure in hemorrhage and heart failure. Am J Physiol Regul Integr Comp Physiol 283:R810, 2002.
11. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure: Part I. Circulation 105:2099, 2002.
12. McMurray J., Pfeffer M.A. New therapeutic options in congestive heart failure: Part II. Circulation 105:2223, 2002.
13. Mehra M.R., Gheorghiade M., Bonow R.O. Mitral regurgitation in chronic heart failure: more questions than answers? Curr Cardiol Rep 6:96, 2004.
14. Pfisterer M. Right ventricular involvement in myocardial infarction and cardiogenic shock. Lancet 362:392, 2003.
15. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24:341, 2003.
16. Shlipak M.G. Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138:917, 2003.
17. Sjaastad I., Wasserstrom J.A., Sejersted O.M. Heart failure — a challenge to our current concepts of excitation-contraction coupling. J Physiol 546:33, 2003.
18. Spodick D.H. Acute cardiac tamponade. N Engl J Med 349:684, 2003.
19. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105:1387, 2002.
20. Zile M.R., Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105:1503, 2002.

1. Arad М., Seidman J.G., Seidman С.Е. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 11:2499, 2002.
2. Braunwald E., Seidman C.E., Sigwart U. Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 106:1312, 2002.
3. Brickner M.E., Hillis L.D., Lange R.A. Congenital heart disease in adults: second of two parts. N Engl J Med 342:334, 2000.
4. Gottdiener J.S. Overview of stress echocardiography: uses, advantages, and limitations. Curr Probl Cardiol 28:485, 2003.
5. Grech E.D. Non-coronary percutaneous intervention. BMJ 327:97, 2003.
6. Guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiolo-gy/American Heart Association Task Force on Practice Guidelines. Circulation 98:1949, 1998.
7. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 39:1890, 2002.
8. Levi D.S., Alejos J.C., Moore J.W. Future of interventional cardiology in pediatrics. Curr Opin Cardiol 18:79, 2003.
9. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308, 2002.
10. McDonald M., Currie B.J., Carapetis J.R. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 4:240, 2004.
11. Nishimura R.A., Holmes D.R. Jr. Clinical practice: hypertrophic obstructive cardiomyopathy. N Engl J Med 350:1320, 2004.
12. Reimold S.C., Rutherford J.D. Clinical practice: valvular heart disease in pregnancy. N Engl J Med 349:52, 2003.
13. Rosenhek R., Burder T., Pozenta G. et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343:611, 2000.
14. Turgeman Y., Atar S., Rosenfeld T. The subvalvular apparatus in rheumatic mitral stenosis: methods of assessment and therapeutic implications. Chest 124:1929, 2003.
15. Yacoub M.H., Cohn L.H. Novel approaches to cardiac valve repair: from structure to function. Part II. Circulation 109:942, 2004.
16. Yoerger D.M., Weyman A.E. Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy. Rev Cardiovasc Med 4:199, 2003.

1. Annane D., Sebille V., Charpentier С. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862, 2002.
2. Burry L.D., Wax R.S. Role of corticosteroids in septic shock. Ann Pharmacother 38:464, 2004.
3. Creteur J., Vincent J.L. Hemoglobin solutions. Crit Care Med 31 (12 Suppl):S698, 2003.
4. Crowell J.W., Guyton A.C. Evidence favoring a cardiac mechanism in irreversible hemorrhagic shock. Am J Physiol 201:893, 1961.
5. Crowell J.W., Smith E.E. Oxygen deficit and irreversible hemorrhagic shock. Am J Physiol 206:313, 1964.
6. de Jonge Е., Levi М. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29:1261, 2001.
7. Goodnough L.T., Shander A. Evolution in alternatives to blood transfusion. Hematol J 4:87, 2003.
8. Granger D.N., Stokes K.Y., Shigematsu T. et al. Splanchnic ischaemia-reperfusion injury: mechanistic insights provided by mutant mice. Acta Physiol Scand 173:83, 2001.
9. Guyton A.C., Jones C.E., Coleman T.G. Circulatory Physiology: Cardiac Output and Its Regulation. Philadelphia: WB Saunders, 1973.
10. Ledgerwood A.M., Lucas C.E. A review of studies on the effects of hemorrhagic shock and resuscitation on the coagulation profile. J Trauma 54 (5 Suppl):S68, 2003.
11. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546, 2003.
12. McLean-Tooke A.P., Bethune C.A., Fay A.C., Spickett G.P. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 327:1332, 2003.
13. Proctor K.G. Blood substitutes and experimental models of trauma. J Trauma 54 (5 Suppl):S106, 2003.
14. Rivers E., Nguyen B., Havstad S. et al. The Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368, 2001.
15. Toh C.H., Dennis M. Disseminated intravascular coagulation: old disease, new hope. BMJ 327:974, 2003.
16. Wernly J.A. Ischemia, reperfusion, and the role of surgery in the treatment of cardiogenic shock secondary to acute myocardial infarction: an interpretative review. J Surg Res 117:6, 2004.
17. Wilson M., Davis D.P., Coimbra R. Diagnosis and monitoring of hemorrhagic shock during the initial resuscitation of multiple trauma patients: a review. J Emerg Med 24:413, 2003.

1. Amiry-Moghaddam М, Ottersen О.Р. The molecular basis of water transport in the brain. Nat Rev Neurosci 4:991, 2003. Aukland K. Why don’t our feet swell in the upright position? News Physiol Sci 9:214, 1994.
2. Basnyat B., Murdoch D.R. High-altitude illness. Lancet 361:1967, 2003.
3. Cho S., Atwood J.E. Peripheral edema. Am J Med 113:580, 2002.
4. Decaux G., Soupart A. Treatment of symptomatic hyponatremia. Am J Med Sci 326:25, 2003.
5. Drake R.E., Doursout M.F. Pulmonary edema and elevated left atrial pressure: four hours and beyond. News Physiol Sci 17:223, 2002.
6. Gashev A.A. Physiologic aspects of lymphatic contractile function: current perspectives. Ann N Y Acad Sci 979:178, 2002.
7. Guyton A.C., Granger H.J., Taylor A.E. Interstitial fluid pressure. Physiol Rev 51:527, 1971.
8. Guyton A.C., Taylor A.E., Granger H.J. Circulatory Physiology II: Dynamics and Control of the Body Fluids. Philadelphia: WB Saunders, 1975.
9. Halperin M.L., Bohn D. Clinical approach to disorders of salt and water balance: emphasis on integrative physiology. Crit Care Clin 18:249, 2002.
10. Jussila L., Alitalo K. Vascular growth factors and lymphangio-genesis. Physiol Rev 82:673, 2002.
11. Matthay M.A., Folkesson H.G., Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 82:569, 2002.
12. Michel C.C. Exchange of fluid and solutes across microvascular walls. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology & Pathophysiology, 3rd ed. Philadelphia: Lippin-cott Williams & Wilkins, 2000.
13. Moritz M.L., Ayus J.C. Disorders of water metabolism in children: hyponatremia and hypernatremia. Pediatr Rev 23:371, 2002.
14. Saaristo A., Karkkainen M.J., Alitalo K. Insights into the molecular pathogenesis and targeted treatment of lymphedema. Ann N Y Acad Sci 979:94, 2002.
15. Winaver J., Abassi Z., Green J., Skorecki K.L. Control of extracellular fluid volume and the pathophysiology of edema formation. In Brenner B.M., Rector F.C. (eds): The Kidney, 6th ed. Philadelphia: WB Saunders, 2000.

1. Beeuwkes R. Ill: The vascular organization of the kidney. An-nu Rev Physiol 42:531, 1980.
2. Bell P.D., Lapointe J.Y., Peti-Peterdi J. Macula densa cell signaling. Annu Rev Physiol 65:481, 2003.
3. Blantz R.C., Deng A., Lortie M. et al. The complex role of nitric oxide in the regulation of glomerular ultrafiltration. Kidney Int 61:782, 2002.
4. Cowley A.W. Jr., Mori T., Mattson D., Zou A.P. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284:R1355, 2003.
5. Davis M.J, Hill M.A. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 79:387, 1999.
6. Deen W.M., Lazzara M.J., Myers B.D. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol 281:F579, 2001.
7. DiBona G.F. Neural control of the kidney: past, present, and future. Hypertension 41:621, 2003.
8. Hall J.E. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 10 (Suppl 12):s258, 1999.
9. Hall J.E., Brands M.W. The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis. In Sel-din D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, p. 1009-1046.
10. Haraldsson B., Sorensson J. Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 19:7, 2004.
11. Kriz W., Kaissling B. Structural organization of the mammalian kidney. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, pp 587-654.
12. Navar L.G., Kobori H., Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 5:135, 2003.
13. Pallone T.L., Zhang Z., Rhinehart K. Physiology of the renal medullary microcirculation. Am J Physiol Renal Physiol 284:F253, 2003.
14. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131, 2002.
15. Schnermann J., Levine D.Z. Paracrine factors in tubuloglome-rular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65:501, 2003.
16. Whelton A. Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors. Am J Med 110 (Suppl 3A):33S, 2001.

1. Aronson P.S. Ion exchangers mediating NaCl transport in the renal proximal tubule. Cell Biochem Biophys 36:147, 2002.
2. Benos D.J., Fuller C.M., Shlyonsky V.G. et al. Amiloride-sensi-tive Na+ channels: insights and outlooks. News Physiol Sci 12:55, 1997.
3. Feraille E., Doucet A. Sodium-potassium-adenosme-triphospha-tase-dependent sodium transport in the kidney: Hormonal control. Physiol Rev 81:345, 2001.
4. Granger J.P., Alexander B.T., Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep 4:152, 2002.
5. Hall J.E., Brands M.W. The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis. In Sel-din D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000.
6. Humphreys M.H., Valentin J-P. Natriuretic hormonal agents. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000.
7. Kellenberger S., Schild L. Epithelial sodium channel/degenerin family of ion channels: A variety of functions for a shared structure. Physiol Rev 82:735, 2002.
8. Nielsen S., Frmkiur, Kr J., Marples D. et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82:205, 2002.
9. Palmer L.G., Frindt G. Aldosterone and potassium secretion by the cortical collecting duct. Kidney Int 57:1324, 2000.
10. Rahn K.H., Heidenreich S., Bruckner D. How to assess glomerular function and damage in humans. J Hypertens 17:309, 1999.
11. Reeves W.B., Andreoli T.E. Sodium chloride transport in the loop of Henle, distal convoluted tubule and collecting duct. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000.
12. Reilly R.F., Ellison D.H. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev 80:277, 2000.
13. Rossier B.C., Praderv S., Schild L., Hummler E. Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. Annu Rev Physiol 64:877, 2002.
14. Russell J.M. Sodium-potassium-chloride cotransport. Physiol Rev 80:211, 2000.
15. Schafer J.A. Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct. Am J Physiol Renal Physiol 283:F221, 2002.
16. Weinstein A.M. Mathematical models of renal fluid and electrolyte transport: acknowledging our uncertainty. Am J Physiol Renal Physiol 284:F871, 2003.
17. Wright E.M. Renal Na(+)-glucose cotransporters. Am J Physiol Renal Physiol 280:F10, 2001.

1. Cowley A.W. Jr., Mori Т., Mattson D., Zou A.P. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284:R1355, 2003.
2. Dwyer T.M., Schmidt-Nielsen B. The renal pelvis: machinery that concentrates urine in the papilla. News Physiol Sci 18:1, 2003.
3. Edwards A., Delong M.J., Pallone T.L. Interstitial water and solute recovery by inner medullary vasa recta. Am J Physiol Renal Physiol 278:F257, 2000.
4. Fitzsimons J.T. Angiotensin, thirst, and sodium appetite. Physiol Rev 78:583, 1998.
5. Knepper M.A., Saidel G.M., Hascall V.C., Dwyer T. Concentration of solutes in the renal inner medulla: interstitial hyalu-ronan as a mechano-osmotic transducer. Am J Physiol Renal Physiol 284:F433, 2003.
6. Kozono D., Yasui M., King L.S., Agre P. Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine. J Clin Invest 109:1395, 2002.
7. McKinley M.J., Johnson A.K. The physiological regulation of thirst and fluid intake. News Physiol Sci 19:1, 2004.
8. Morello J.P., Bichet D.G. Nephrogenic diabetes insipidus. Annu Rev Physiol 63:607, 2001.
9. Nielsen S., Frokiaer J., Marples D. et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82:205, 2002.
10. Pallone T.L., Turner M.R., Edwards A., Jamison R.L. Countercurrent exchange in the renal medulla. Am J Physiol Regul Integr Comp Physiol 284:R1153, 2003.
11. Robertson G.L. Vasopressin. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000.
12. Sands J.M., Layton H.E. Urine concentrating mechanism and its regulation. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000.
13. Sands J.M. Molecular mechanisms of urea transport. J Membrane Biol 191:149, 2003.
14. Strieker E.M., Sved A.F. Controls of vasopressin secretion and thirst: similarities and dissimilarities in signals. Physiol Behav 77:731, 2002.
15. Verbalis J.G. Diabetes insipidus. Rev Endocr Metab Disord 4:177, 2003.

1. Antunes-Rodrigues J., de Castro М, Elias L.L. et al. Neuroendocrine control of body fluid metabolism. Physiol Rev 84:169, 2004.
2. Cowley A.W. Jr. Long-term control of arterial pressure. Physiol Rev 72:231, 1992.
3. Fitzsimmons J.T. Physiology and pathophysiology of thirst and salt appetite. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, p. 1153-1174.
4. Giebisch G.H. A trail of research on potassium. Kidney Int 62:1498, 2002.
5. Giebisch G., Hebert S.C., Wang W.H. New aspects of renal potassium transport. Pflugers Arch 446:289, 2003.
6. Granger J.P., Alexander B.T., Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep 4:15, 2002.
7. Guise T.A., Mundy G.R. Disorders of calcium metabolism. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, p. 1811-1840.
8. Guyton A.C. Blood pressure control — special role of the kidneys and body fluids. Science 252:1813, 1991.
9. Hall J.E. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 10 (Suppl 12):258, 1999.
10. Hall J.E., Brands M.W. The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis. In Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, p. 1009-1046.
11. Murer H., Hernando N., Forster I., Biber J. Regulation of Na/Pi transporter in the proximal tubule. Annu Rev Physiol 65:531, 2003.
12. Rosa R., Epstein F.H. Extrarenal potassium metabolism. In: Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, p. 1551-1574.
13. Suki W.N., Lederer E.D., Rouse D. Renal transport of calcium magnesium and phosphate. In: Brenner B.M. (ed): The Kidney, 6th ed. Philadelphia: WB Saunders, 2000, p. 520-574.
14. Warnock D.G. Renal genetic disorders related to K+ and Mg2+ Annu Rev Physiol 64:845, 2002.
15. Young D.B. Quantitative analysis of aldosterone’s role in potassium regulation. Am J Physiol 255: F811, 1988.
16. Young D.B. Analysis of long-term potassium regulation. Endocr Rev 6:24, 1985.

1. Alpern R.J. Renal acidification mechanisms. In: Brenner B.M. (ed): The Kidney, 6th ed. Philadelphia: WB Saunders, 2000, p. 455-519.
2. Capasso G., Unwin R., Rizzo M. et al. Bicarbonate transport along the loop of Henle: molecular mechanisms and regulation. J Nephrol 15 (Suppl 5):S88, 2002.
3. Decoursey T.E. Voltage-gated proton channels and other proton transfer pathways. Physiol Rev 83:475, 2003.
4. Gennari F.J., Maddox D.A. Renal regulation of acid-base homeostasis. In: Seldin D.W., Giebisch G (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, p. 2015-2054.
5. Good D.W. Ammonium transport by the thick ascending limb of Henle’s loop. Ann Rev Physiol 56:623, 1994.
6. Igarashi I., Sekine T., Inatomi J., Seki G. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol 13:2171, 2002.
7. Karet F.E. Inherited distal renal tubular acidosis. J Am Soc Nephrol 13:2178, 2002.
8. Laffey J.G., Kavanagh B.P. Hypocapnia. N Engl J Med 347:43, 2002.
9. Lemann J. Jr., Bushinsky D.A., Hamm L.L. Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 285:F811, 2003.
10. Madias N.E., Adrogue H.J. Cross-talk between two organs: how the kidney responds to disruption of acid-base balance by the lung. Nephron Physiol 93:61, 2003.
11. Wagner C.A., Geibel J.P. Acid-base transport in the collecting duct. J Nephrol 15 (Suppl 5):S112, 2002.
12. Wesson D.E., Alpern R.J., Seldin D.W. Clinical syndromes of metabolic alkalosis. In: Seldin D.W., Giebisch G. (eds): The Kidney — Physiology and Pathophysiology, 3rd ed. New York: Raven Press, 2000, pp. 2055-2072.
13. White N.H. Management of diabetic ketoacidosis. Rev Endocr Metab Disord 4:343, 2003.

1. Andreoli Т.Е. (ed): Cecil’s Essentials of Medicine, 6th ed. Philadelphia: WB Saunders, 2004.
2. Fishbane S.A., Scribner B.H. Blood pressure control in dialysis patients. Semin Dial 15:144, 2002.
3. Hall J.E. The kidney, hypertension, and obesity. Hypertension 41:625, 2003.
4. Hall J.E., Henegar J.R., Dwyer T.M. et al. Is obesity a major cause of chronic renal disease? Adv Ren Replace Ther 11:41, 2004.
5. Hostetter T.H. Prevention of the development and progression of renal disease. J Am Soc Nephrol 14 (Suppl 2):S144, 2003.
6. Levey A.S., Beto J.A., Coronado B.E. et al. Controlling the epidemic of cardiovascular disease in chronic renal disease. What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32:853, 1998.
7. Luke R.G. Chronic renal failure. In: Goldman F., Bennett J.C. (eds): Cecil Textbook of Medicine, 21st ed. Philadelphia: WB Saunders, 2000, p. 571-578.
8. Mitch W.E. Acute renal failure. In: Goldman F., Bennett J.C. (eds): Cecil Textbook of Medicine, 21st ed. Philadelphia: WB Saunders, 2000, p. 567-570.
9. Molitoris B.A. Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 14:265, 2003.
10. Sarnak M.J., Levey A.S., Schoolwerth A.C. et al. Kidney disease as a risk factor for development of cardiovascular disease. Hypertension 42:1050, 2003.
11. Schrier R.W. Atlas of Diseases of the Kidney.
12. Shankar S.S., Brater D.C. Loop diuretics: from the Na-K-2C1 transporter to clinical use. Am J Physiol Renal Physiol 284:F11, 2003.
13. Singri N., Ahya S.N., Levin M.L. Acute renal failure. JAMA 289:747, 2003.
14. United States Renal Data System.
15. Wilcox C.S. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 13:798, 2002.

1. Alayash АЛ. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 3:152, 2004.
2. Brissot P., Troadec M.B., Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr Hema-tol Rep 3:107, 2004.
3. Claster S., Vichinsky E.P. Managing sickle cell disease. BMJ 327:1151, 2003.
4. Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol 286:R977, 2004.
5. Hallberg L. Perspectives on nutritional iron deficiency. Annu Rev Nutr 21:1, 2001.
6. Hentze M.W., Muckenthaler M.U., Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285, 2004.
7. Lappin T. The cellular biology of erythropoietin receptors. Oncologist 8(Suppl 1): 15, 2003.
8. Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 14:2712, 2003.
9. Persons D.A. Update on gene therapy for hemoglobin disorders. Curr Opin Mol Ther 5:508, 2003.
10. Pietrangelo A. Hereditary hemochromatosis — a new look at an old disease. N Engl J Med 350:2383, 2004.
11. Shah S., Vega R. Hereditary spherocytosis. Pediatr Rev 25:168, 2004.
12. Tefferi A. A contemporary approach to the diagnosis and management of polycythemia vera. Curr Hematol Rep 2:237, 2003.
13. Trigg M.E. Hematopoietic stem cells. Pediatrics 113 (4 Suppl): 1051, 2004.

1. Alexander J.S., Granger D.N. Lymphocyte trafficking mediated by vascular adhesion protein-1: implications for immune targeting and cardiovascular disease. Circ Res 86:1190, 2000.
2. Blander J.M., Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014, 2004.
3. Bleakley M., Riddell S.R. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 4:371, 2004.
4. Ferrajoli A., O’Brien S.M. Treatment of chronic lymphocytic leukemia. Semin Oncol 31(Suppl 4):60, 2004.
5. Heasman S.J., Giles K.M., Ward C. et al. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol 178:29, 2003.
6. Kunkel E.J., Butcher E.C. Plasma-cell homing. Nat Rev Immunol 3:822, 2003.
7. Kvietys P.R., Sandig M. Neutrophil diapedesis: paracellular or transcellular? News Physiol Sci 16:15, 2001.
8. Ley K., Kansas G.S. Selectins in T-cell recruitment to nonlymphoid tissues and sites of inflammation. Nat Rev Immunol 4:325, 2004.
9. Moser B., Wolf M., Walz A., Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75, 2004.
10. Muller W.A. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327, 2003.
11. Ossovskaya V.S., Bunnett N.W. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84:579, 2004.
12. Park J.E., Barbul A. Understanding the role of immune regulation in wound healing. Am J Surg 187:1 IS, 2004.
13. Pui C.H., Relling M.V., Downing J.R. Acute lymphoblastic leukemia. N Engl J Med 350:1535, 2004.
14. Roufosse F., Cogan E., Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 54:169, 2003.
15. von Herrath M.G., Harrison L.C. Regulatory lymphocytes: antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 3:223, 2003.
16. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835, 2003.
17. Zullig S., Hengartner M.O. Cell biology: tickling macrophages, a serious business. Science 304:1123, 2004.

1. Abreu ?.?., Arditi ?. Innate immunity and toll-like receptors: clinical implications of basic science research. J Pediatr 144(4):421, 2004.
2. Albert M.L. Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 4:223, 2004.
3. Alberts B., Johnson A., Lewis J. et al. Molecular Biology of the Cell. New York: Garland Science, 2002.
4. Cheroutre H., Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nat Rev Immunol 4:290, 2004.
5. Cooper M.A., Pommering T.L., Koranyi K. Primary immunodeficiencies. Am Fam Physician 68:2001, 2003.
6. Cossart P., Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304:242, 2004.
7. Eisenbarth G.S., Gottlieb P.A. Autoimmune polyendocrine syndromes. N Engl J Med. 350:2068, 2004.
8. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med 10:475, 2004.
9. Frossi B., De Carli M., Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J Leukoc Biol 75:579, 2004.
10. Grossman Z., Min B., Meier-Schellersheim M., Paul W.E. Concomitant regulation of T-cell activation and homeostasis. Nat Rev Immunol 4:387, 2004.
11. Kupper T.S., Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4:211, 2004.
12. La Cava A., Matarese G. The weight of leptin in immunity. Nat Rev Immunol 4:371, 2004.
13. Linton P.J., Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol 5:133, 2004.
14. MacGlashan D. Jr. Histamine: a mediator of inflammation. J Allergy Clin Immunol 112 (4 Suppl):S53, 2003.
15. McGeady S.J. Immunocompetence and allergy. Pediatrics 113(4 Suppl):l 107, 2004.
16. Nikolich-Zugich J., Slifka M.K., Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol 4:123, 2004.
17. Petrie H.T. Cell migration and the control of post-natal T-cell lymphopoiesis in the thymus. Nat Rev Immunol 3:859, 2003.
18. Scott C.C., Botelho R.J., Grinstein S. Phagosome maturation: a few bugs in the system. J. Membr Biol 193:137, 2003.
19. Theoharides T.C., Cochrane D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuro-immunol 146:1, 2004.
20. Vivier E., Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 4:190, 2004.

1. Alayash АЛ. Oxygen therapeutics: can we tame haemoglobin? Nat Rev Drug Discov 3:152, 2004.
2. Altomonte M., Fonsatti E., Visintin A., Maio M. Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? Oncogene 22:6564, 2003.
3. Avent N.D., Reid M.E. The Rh blood group system: a review. Blood 95:375, 2000.
4. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion 43:1661, 2003.
5. Goodnough L.T., Shander A. Evolution in alternatives to blood transfusion. Hematol J 4:87, 2003.
6. Gottstein R., Cooke R.W. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 88:F6, 2003.
7. Heeger P.S. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 3:525, 2003.
8. Horn K.D. The classification, recognition and significance of polyagglutination in transfusion medicine. Blood Rev 13:36, 1999.
9. Miller J., Mathew J.M., Esquenazi V. Toward tolerance to human organ transplants: a few additional corollaries and questions. Transplantation 77:940, 2004.
10. Ricordi C., Strom T.B. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 4:259, 2004.
11. Schroeder R.A., Marroquin C.E., Kuo P.C. Tolerance and the «Holy Grail» of transplantation. J Surg Res 111:109, 2003.
12. Schulak J.A. Steroid immunosuppression in kidney transplantation: a passing era. J Surg Res 117:154, 2004.
13. Spahn D.R., Pasch T. Physiological properties of blood substitutes. News Physiol Sci 16:38, 2001.
14. Strober S., Lowsky R.J., Shizuru J.A. et al. Approaches to transplantation tolerance in humans. Transplantation 77:932, 2004.
15. Sumpter T.L., Wilkes D.S. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol 286:L1129, 2004.
16. Telen M.J. Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease. Semin Hematol 37:130, 2000.
17. Trigg M.E. Hematopoietic stem cells. Pediatrics 113(4 Suppl):1051, 2004.
18. Triulzi D.J. Specialized transfusion support for solid organ transplantation. Curr Opin Hematol 9:527, 2002.

1. Brass L.F. Thrombin and platelet activation. Chest 124 (3 Suppl):18S, 2003.
2. Caprini J.A., Glase C.J., Anderson C.B., Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation 109 (12 Suppl 1):I4, 2004.
3. Dorsam R.T., Kunapuli S.P. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113:340, 2004.
4. Fisher М., Brott T.G. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke 34:359, 2003.
5. Geddis A.E., Kaushansky K. Inherited thrombocytopenias: toward a molecular understanding of disorders of platelet production. Curr Opin Pediatr 16:15, 2004.
6. Kahn S.R., Ginsberg J.S. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 164:17, 2004.
7. Koreth R., Weinert C., Weisdorf D.J., Key N.S. Measurement of bleeding severity: a critical review. Transfusion 44:605, 2004.
8. Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 124:567, 2004.
9. Lindsberg P.J., Kaste M. Thrombolysis for acute stroke. Curr Opin Neurol 16:73, 2003.
10. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347:589, 2002.
11. Roberts H.R., Monroe D.M., Escobar M.A. Current concepts of hemostasis: implications for therapy. Anesthesiology 100:722, 2004.
12. Saenko E.L., Ananyeva N.M., Shima M. et al. The future of recombinant coagulation factors. J Thromb Haemost 1:922, 2003.
13. Solum N.O. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vase Biol 19:2841, 1999.
14. Toh C.H., Dennis M. Disseminated intravascular coagulation: old disease, new hope. BMJ 327:974, 2003.
15. Tsai H.M. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 14:1072, 2003.
16. Tsai H.M. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Arterioscler Thromb Vase Biol 23:388, 2003.
17. VandenDriessche T., Collen D., Chuah M.K. Gene therapy for the hemophilias. J Thromb Haemost 1:1550, 2003.
18. Vesely S.K., Perdue J.J., Rizvi M.A. et al. Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med 140:112, 2004.
19. White R.H., Ginsberg J.S. Low-molecular-weight heparins: are they all the same? Br J Haematol 121:12, 2003.

1. Carr M.J., Undem B.J. Bronchopulmonary afferent nerves. Res-pirology 8:291, 2003.
2. Coulson F.R., Fryer A.D. Muscarinic acetylcholine receptors and airway diseases. Pharmacol Ther 98:59, 2003.
3. Daniels C.B., Orgeig S. Pulmonary surfactant: the key to the evolution of air breathing. News Physiol Sci 18:151, 2003.
4. Foster W.M. Mucociliary transport and cough in humans. Pulm Pharmacol Ther 15:277, 2002.
5. Haitsma J.J., Papadakos P.J., Lachmann В. Surfactant therapy for acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 10:18, 2004.
6. Hilaire G., Duron B. Maturation of the mammalian respiratory system. Physiol Rev 79:325, 1999.
7. Lai-Fook S.J. Pleural mechanics and fluid exchange. Physiol Rev 84:385, 2004.
8. Mason R.J., Greene K., Voelker D.R. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol Lung Cell Mol Physiol 275:L1, 1998.
9. Massaro D., Massaro G.D. Pulmonary alveoli: formation, the «call for oxygen», and other regulators. Am J Physiol Lung Cell Mol Physiol 282:L345, 2002.
10. Maxfield R.A. New and emerging minimally invasive techniques for lung volume reduction. Chest 125:777, 2004.
11. McConnell A.K., Romer L.M. Dyspnoea in health and obstructive pulmonary disease: the role of respiratory muscle function and training. Sports Med 34:117, 2004.
12. Paton J.F., Dutschmann M. Central control of upper airway resistance regulating respiratory airflow in mammals. J Anat 201:319, 2002.
13. Powell F.L., Hopkins S.R. Comparative physiology of lung complexity: implications for gas exchange. News Physiol Sci 19:55, 2004.
14. Sant’Ambrogio G., Widdicombe J. Reflexes from airway rapidly adapting receptors. Respir Physiol 125:33, 2001.
15. Uhlig S., Taylor A.E. Methods in Pulmonary Research. Basel: Birkhauser Verlag, 1998.
16. West J.B. Respiratory Physiology. New York: Oxford University Press, 1996.
17. West J.B. Why doesn’t the elephant have a pleural space? News Physiol Sci 17:47, 2002.
18. Widdicombe J. Neuroregulation of cough: implications for drug therapy. Curr Opin Pharmacol 2:256, 2002.
19. Wright J.R. Pulmonary surfactant: a front line of lung host defense. J Clin Invest 111:1453, 2003.
20. Zeitels S.M., Healy G.B. Laryngology and phonosurgery. N Engl J Med 349:882, 2003.

1. Gehlbach В.К., Geppert Е. The pulmonary manifestations of left heart failure. Chest 125:669, 2004.
2. Guazzi M. Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest 124:1090, 2003.
3. Guyton A.C., Lindsey A.W. Effect of elevated left atrial pressure and decreased plasma protein concentration on the development of pulmonary edema. Circ Res 7:649, 1959.
4. Guyton A.C., Parker J.C., Taylor A.E. et al. Forces governing water movement in the lung. In: Fishman AP, Renkin EM (eds): Pulmonary Edema. Baltimore: Waverly Press, 1979, p. 65.
5. Guyton A.C., Taylor A.E., Granger H.J. Circulatory Physiology. II. Dynamics and Control of the Body Fluids. Philadelphia: WB Saunders, 1975.
6. Hoschele S., Mairbaurl H. Alveolar flooding at high altitude: failure of reabsorption? News Physiol Sci 18:55, 2003.
7. Lai-Fook S.J. Pleural mechanics and fluid exchange. Physiol Rev 84:385, 2004.
8. Matalon S., Hardiman K.M., Jain L. et al. Regulation of ion channel structure and function by reactive oxygen-nitrogen species. Am J Physiol Lung Cell Mol Physiol 285:L1184, 2003.
9. Miserocchi G., Negrini D., Passi A., De Luca G. Development of lung edema: interstitial fluid dynamics and molecular structure. News Physiol Sci 16:66, 2001.
10. Schoene R.B. Limits of human lung function at high altitude. J Exp Biol 204:3121, 2001.
11. Taylor A.E., Guyton A.C., Bishop V.S. Permeability of the alveolar membrane to solutes. Circ Res 16:353, 1965.
12. Wallace J. Update in pulmonary diseases. Ann Intern Med 139:499, 2003.
13. West J.B. Respiratory Physiology — The Essentials, 5th ed. Baltimore: Williams & Wilkins, 1994.
14. West J.B. Invited review: pulmonary capillary stress failure. J Appl Physiol 89:2483, 2000.

1. Albert R., Spiro S., Jett J. Comprehensive Respiratory Medicine. Philadelphia: Mosby, 2002.
2. Cole R.P. CO2 and lung mechanical or gas exchange function. Crit Care Med 32:1240, 2004.
3. Guazzi M. Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest 124:1090, 2003.
4. Hsia C.C. Recruitment of lung diffusing capacity: update of concept and application. Chest 122:1774, 2002.
5. Knight D.A., Holgate S.T. The airway epithelium: structural and functional properties in health and disease. Respirology 8:432, 2003.
6. Otis A.B. Quantitative relationships in steady-state gas exchange. In: Fenn W.Q., Rahn H. (eds): Handbook of Physiology. Sec 3, Vol 1. Baltimore: Williams & Wilkins, 1964, p. 681.
7. Parker J.C., Townsley M.I. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol 286:L231, 2004.
8. Powell F.L., Hopkins S.R. Comparative physiology of lung complexity: implications for gas exchange. News Physiol Sci 19:55, 2004.
9. Rahn H., Farhi E.E. Ventilation, perfusion, and gas exchange— the Va/Q concept. In: Fenn W.O., Rahn H. (eds): Handbook of Physiology. Sec 3, Vol 1. Baltimore: Williams & Wilkins, 1964, p. 125.
10. Uhlig S., Taylor A.E. Methods in Pulmonary Research. Basel: Birkhauser Verlag, 1998.
11. West J.B. Pulmonary Physiology and Pathophysiology: An Integrated, Case-Based Approach. Philadelphia: Lippincott Williams & Wilkins, 2001.
12. West J.B. Pulmonary Physiology — The Essentials. Baltimore: Lippincott Williams & Wilkins, 2003.
13. Williams M.C. Alveolar type I cells: molecular phenotype and development. Annu Rev Physiol 65:669, 2003.

1. Albert R., Spiro S., Jett J. Comprehensive Respiratory Medicine. Philadelphia: Mosby, 2002.
2. Dempsey J.A., Wagner P.D. Exercise-induced arterial hypoxemia. J Appl Physiol 87:1997, 1999.
3. Geers C., Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev 80:681, 2000.
4. Henry R.P., Swenson E.R. The distribution and physiological significance of carbonic anhydrase in vertebrate gas exchange organs. Respir Physiol 121:1, 2000.
5. Jones A.M., Koppo K., Burnley M. Effects of prior exercise on metabolic and gas exchange responses to exercise. Sports Med 33:949, 2003.
6. Nikinmaa M. Membrane transport and control of hemoglobin-oxygen affinity in nucleated erythrocytes. Physiol Rev 72:301, 1992.
7. Piiper J. Perfusion, diffusion and their heterogeneities limiting blood-tissue O2 transfer in muscle. Acta Physiol Scand 168:603, 2000.
8. Richardson R.S. Oxygen transport and utilization: an integration of the muscle systems. Adv Physiol Educ 27:183, 2003.
9. Roy T.K., Popel A.S. Theoretical predictions of end-capillary P02 in muscles of athletic and nonathletic animals at Vo2max Am J Physiol 27LH721, 1996.
10. Spahn D.R., Pasch T. Physiological properties of blood substitutes. News Physiol Sci 16:38, 2001.
11. Tsai A.G., Johnson P.C., Intaglietta M. Oxygen gradients in the microcirculation. Physiol Rev 83:933, 2003.
12. Wagner P.D. Diffusive resistance to O2 transport in muscle. Acta Physiol Scand 168:609, 2000.
13. West J.B. Pulmonary Physiology and Pathophysiology: An Integrated, Case-Based Approach. Philadelphia: Lippincott Williams 8c Wilkins, 2001.
14. West J.B. Pulmonary Physiology — The Essentials. Baltimore: Lippincott Williams 8c Wilkins, 2003.

1. Dean J.B., Ballantyne D., Cardone D.L. et al. Role of gap junctions in CO2 chemoreception and respiratory control. Am J Physiol Lung Cell Mol Physiol 283:L665, 2002.
2. Dutschmann M., Paton J.F. Inhibitory synaptic mechanisms regulating upper airway patency. Respir Physiol Neurobiol 131:57, 2002.
3. Feldman J.L., Mitchell G.S., Nattie E.E. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci 26:239, 2003.
4. Forster H.V. Plasticity in the control of breathing following sensory denervation. J Appl Physiol 94:784, 2003.
5. Hilaire G., Pasaro R. Genesis and control of the respiratory rhythm in adult mammals. News Physiol Sci 18:23, 2003.
6. Howard R.S., Rudd A.G., Wolfe C.D., Williams A.J. Pathophysiological and clinical aspects of breathing after stroke. Postgrad Med J 77:700, 2001.
7. Jordan D. Central nervous pathways and control of the airways. Respir Physiol 125:67, 2001.
8. Kara T., Narkiewicz K., Somers V.K. Chemoreflexes — physiology and clinical implications. Acta Physiol Scand 177:377, 2003.
9. Morris K.F., Baekey D.M., Nuding S.C. et al. Neural network plasticity in respiratory control. J Appl Physiol 94:1242, 2003.
10. Mortola J.P., Frappell Р.В. Ventilatory responses to changes in temperature in mammals and other vertebrates. Annu Rev Physiol 62:847, 2000.
11. Richerson G.B. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 5:449, 2004.
12. Semenza G.L. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96:1173, 2004.
13. Sharp F.R., Bernaudin M. HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5:437, 2004.
14. Taylor E.W., Jordan D., Coote J.H. Central control of the cardiovascular and respiratory systems and their interactions in vertebrates. Physiol Rev 79:855, 1999.
15. West J.B. Pulmonary Physiology — The Essentials. Baltimore: Lippincott Williams & Wilkins, 2003.
16. Wolk R., Shamsuzzaman A.S., Somers V.K. Obesity, sleep apnea, and hypertension. Hypertension 42:1067, 2003.
17. Young T., Skatrud J., Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 291:2013, 2004.
18. Zuperku E.J., McCrimmon D.R. Gain modulation of respiratory neurons. Respir Physiol Neurobiol 131:121, 2002.

1. Albert R., Spiro S., Jett J. Comprehensive Respiratory Medicine. Philadelphia: Mosby, 2002.
2. Barnes P.J., Adcock I.M. How do corticosteroids work in asthma? Ann Intern Med 139:359, 2003.
3. Basu S., Fenton M.J. Toll-like receptors: function and roles in lung disease. Am J Physiol Lung Cell Mol Physiol 286:L887, 2004.
4. Cardoso W.V. Molecular regulation of lung development. Annu Rev Physiol 63:471, 2001.
5. Carter E.P., Garat C, Imamura M. Continual emerging roles of HO-T. protection against airway inflammation. Am J Physiol Lung Cell Mol Physiol 287:L24, 2004.
6. Dwyer T.M. Cigarette smoke-induced airway inflammation as sampled by the expired breath condensate. Am J Med Sci 326:174, 2003.
7. Knight D. A., Holgate S.T. The airway epithelium: structural and functional properties in health and disease. Respirology 8:432, 2003.
8. McConnell A.K., Romer L.M. Dyspnoea in health and obstructive pulmonary disease: the role of respiratory muscle function and training. Sports Med 34:117, 2004.
9. Naureckas E.T., Solway J. Clinical practice. Mild asthma. N Engl J Med 345:1257, 2001.
10. Page S., Ammit A..J, Black J.L., Armour C.L. Human mast cell and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol 28TL1313, 2001.
11. Rodrigo G.J., Rodrigo C, Hall J.B. Acute asthma in adults: a review. Chest 125:1081, 2004.
12. Schwiebert L.M. Cystic fibrosis, gene therapy, and lung inflammation: for better or worse? Am J Physiol Lung Cell Mol Physiol 286:L715, 2004..
13. Sin D.D., McAlister F.A., Man S.F., Anthonisen N.R. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 290:2301, 2003.
14. Wardlaw A.J., Brightling C.E., Green R. et al. New insights into the relationship between airway inflammation and asthma. Clin Sci(Lond) 103:201, 2002.
15. West J.B. Pulmonary Physiology and Pathophysiology: An Integrated, Case-Based Approach. Philadelphia: Lippincott Williams 8c Wilkins, 2001.
16. Whitsett J.A., Weaver T.E. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347:2141, 2002.
17. Wills-Karp M., Ewart S.L. Time to draw breath: asthma-susceptibility genes are identified. Nat Rev Genet 5:376, 2004.

1. Adams G.R., Caiozzo V.J., Baldwin К.М. Skeletal muscle unweighting: spaceflight and ground-based models. J Appl Physiol 95:2185, 2003.
2. Alfrey C.P., Udden M.M., Leach-Huntoon C. et al. Control of red blood cell mass in spaceflight. J Appl Physiol 81:98, 1996. Basnyat B., Murdoch D.R. High-altitude illness. Lancet 361:1967, 2003.
3. Convertino V.A. Mechanisms of microgravity induced orthostatic intolerance: implications for effective countermeasures. J Gravit Physiol 9:1, 2002.
4. Eckberg D.L. Bursting into space: alterations of sympathetic control by space travel. Acta Physiol Scand 177:299, 2003.
5. Hackett P.H., Roach R.C. High-altitude illness. N Engl J Med 345:107, 2001.
6. Harm D.L., Jennings R.T., Meek J.V. et al. Gender issues related to spaceflight: a NASA perspective. J Appl Physiol 91:2374, 2001.
7. Hochachka P.W., Beatty C.L., Burelle Y. et al. The lactate paradox in human high-altitude physiological performance. News Physiol Sci 17:122, 2002.
8. Hoschele S., Mairbaurl H. Alveolar flooding at high altitude: failure of reabsorption? News Physiol Sci 18:55, 2003.
9. Hultgren H.N. High-altitude pulmonary edema: current concepts. Annu Rev Med 47:267, 1996.
10. Rupert J.L., Hochachka P.W. Genetic approaches to understanding human adaptation to altitude in the Andes. J Exp Biol 204 (Pt 18):3151, 2001.
11. Smith S.M., Heer M. Calcium and bone metabolism during space flight. Nutrition 18:849, 2002.
12. West J.B. Climbing Mount Everest without oxygen. News Physiol Sci 1:25, 1986.
13. West J.B. Man in space. News Physiol Sci 1:198, 1986.
14. West J.B. High Life — History of High-Altitude Physiology and Medicine. Bethesda, MD: American Physiological Society, 1998.
15. Zhang L.F. Vascular adaptation to microgravity: what have we learned? J Appl Physiol 91:2415, 2001.

1. Butler P.J. Diving beyond the limits. News Physiol Sci 16:222, 2001.
2. Kooyman G.L., Ponganis P.J. The physiological basis of diving to depth: birds and mammals. Annu Rev Physiol 60:19, 1998.
3. Leach R.M., Rees P.J., Wilmshurst P. Hyperbaric oxygen therapy. BMJ 317:1140, 1998.
4. Neuman T.S. Arterial gas embolism and decompression sickness. News Physiol Sci 17:77, 2002.
5. Nilsson G.E. Surviving anoxia with the brain turned on. News Physiol Sci 16:217, 2001.
6. Russi E.W. Diving and the risk of barotrauma. Thorax 53(Suppl 2):S20, 1998.
7. Wang C., Schwaitzberg S., Berliner E. et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 138:272, 2003.
8. Wang J., Li F., Calhoun J.H., Mader J.T. The role and effectiveness of adjunctive hyperbaric oxygen therapy in the management of musculoskeletal disorders. J Postgrad Med 48:226, 2002.
9. West J.B., Fu Z., Gaeth A.P., Short R.V. Fetal lung development in the elephant reflects the adaptations required for snorkeling in adult life. Respir Physiol Neurobiol 138:325, 2003.

1. Albright T.D., Jessell Т.М., Kandell E.R., Posner M.I. Progress in the neural sciences in the century after Cajal (and the mysteries that remain). Ann N Y Acad Sci 929:11, 2001.
2. Boehning D., Snyder S.H. Novel neural modulators. Annu Rev Neurosci 26:105, 2003.
3. Brasnjo G., Otis T.S. Glycine transporters not only take out the garbage, they recycle. Neuron 40:667, 2003.
4. Cowley M.A., Cone R.D., Enriori P. et al. Electrophysiological actions of peripheral hormones on melanocortin neurons. Ann N Y Acad Sci 994:175, 2003.
5. Engelman H.S., MacDermott A.B. Presynaptic inotropic receptors and control of transmitter release. Nat Rev Neurosci 5:135, 2004.
6. Girault J.A., Greengard P. The neurobiology of dopamine signaling. Arch Neurol 61:641, 2004.
7. Haines D.E. Fundamental Neuroscience. New York: Churchill Livingstone, 1997.
8. Haines D.E., Lancon J.A. Review of Neuroscience. New York: Churchill Livingstone, 2003.
9. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294:1030, 2001.
10. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
11. Magee J.C. Dendritic integration of excitatory synaptic input. Nat Rev Neurosci 1:181, 2000.
12. Migliore M., Shepherd G.M. Emerging rules for the distributions of active dendritic conductances. Nat Rev Neurosci 3:362, 2002.
13. Muller D., Nikonenko I. Dynamic presynaptic varicosities: a role in activity-dependent synaptogenesis. Trends Neurosci 26:573, 2003.
14. Nicholls D.G., Budd S.L. Mitochondria and neuronal survival. Physiol Rev 80:315, 2000.
15. Nimchinsky E.A., Sabatin B.L., Svoboda K. Structure and function of dendritic spines. Annu Rev Physiol 64:313, 2002.
16. Prast H., Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol 64:51, 2001.
17. Reid C.A., Bekkers J.M., Clements J.D. Presynaptic Ca2+ channels: a functional patchwork. Trends Neurosci 26:683, 2003.
18. Robinson R.B., Siegelbaum S.A. Hyperpolarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 65:453, 2003.
19. Ruff R.L. Neurophysiology of the neuromuscular junction: overview. Ann N Y Acad Sci 998:1, 2003.
20. Schmolesky M.T., Weber J.T., De Zeeuw C.I., Hansel C. The making of a complex spike: ionic composition and plasticity. Ann N Y Acad Sci 978:359, 2002.
21. Semyanov A., Walker M.C., Kullmann D.M., Silver R.A. Toni-cally active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 27:262, 2004.
22. Stern J.E. Nitric oxide and homeostatic control: an intercellular signaling molecule contributing to autonomic and neuroendocrine integration? Prog Biophys Mol Biol 84:197, 2004.
23. Timofeev I., Steriade M. Neocortical seizures: initiation, development and cessation. Neuroscience 123:299, 2004.
24. Tsay D., Yuste R.L. On the electrical function of dendritic spines. Trends Neurosci 27:77, 2004.
25. West A.R., Floresco S.B., Charara A. et al. Electrophysiological interactions between striatal glutamatergic and dopaminergic systems. Ann N Y Acad Sci 1003:53, 2003.
26. Williams S.R., Stuart G.J. Role of dendritic synapse location in the control of action potential output. Trends Neurosci 26:147, 2003.
27. Zucker R.S., Regehr W.G. Short-term synaptic plasticity. Annu Rev Physiol 64:355, 2002.

1. Baev K.V. Biological Neural Networks. Boston: Birkhauser, 1998.
2. Basar E. Brain Function and Oscillations. Berlin: Springer, 1998.
3. Buzsaki G. Large-scale recording of neuronal ensembles. Nat Neurosci 7:446, 2004.
4. Fain G.L., Matthews H.R., Cornwall M.C., Koutalos Y. Adaptation in vertebrate photoreceptors. Physiol Rev 81:117, 2001.
5. Gandevia S.C. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 81:1725, 2001.
6. Gebhart G.F. Descending modulation of pain. Neurosci Biob-ehav Rev 27:729, 2004.
7. Hamill O.P., Martinac B. Molecular basis of mechanotrans-duc-tion in living cells. Physiol Rev 81:685, 2001.
8. Ivry R.B., Robertson L.C. The Two Sides of Perception. Cambridge, MA: MIT Press, 1998.
9. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
10. Krupa B., Liu G. Does the fusion pore contribute to synaptic plasticity? Trends Neurosci 27:62, 2004.
11. McLachlan E.M. Transmission of signals through sympathetic ganglia—modulation, integration or simply distribution? Acta Physiol Scand 177:227, 2003.
12. Mombaerts P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat Rev Neurosci 5:263, 2004.
13. Palmer M.J., von Gersdorff H. Phasic transmitter release from tonic neurons. Neuron 35:600, 2002.
14. Pearson K.G. Neural adaptation in the generation of rhythmic behavior. Annu Rev Physiol 62:723, 2000.
15. Renteria R.C., Johnson J., Copenhagen D.R. Need rods? Get glycine receptors and taurine. Neuron 41:839, 2004.
16. Richerson G.B., Wu Y. Dynamic equilibrium of neurotransmitter transporters: not just for reuptake anymore. J Neurophysiol 90:1363, 2003.
17. Schwartz E.A. Transport-mediated synapses in the retina. Physiol Rev 82:875, 2002.
18. Shen K. Molecular mechanisms of target specificity during synapse formation. Curr Opin Neurobiol 14:83, 2004.
19. Williams J.T., Christie M.J., Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299, 2001.

1. Bosco G., Poppele R.E. Proprioception from a spinocerebel-lar perspective. Physiol Rev 81:539, 2001.
2. Chen R., Cohen L.G., Hallett M. Nervous system reorganization following injury. Neuroscience 111 (4):761, 2002.
3. Cohen Y.E., Andersen R.A. A common reference frame for movement plans in the posterior parietal cortex. Nat Rev Neurosci 3:553, 2002.
4. Craig A.D. Pain mechanisms: labeled lines versus convergence in central processing. Annu Rev Neurosci 26:1, 2003.
5. Foeller E., Feldman D.E. Synaptic basis for developmental plasticity in somatosensory cortex. Curr Opin Neurobiol 14:89, 2004.
6. Haines D.E. Fundamental Neuroscience. New York: Churchill Livingstone, 1997.
7. Haines D.E., Lancon J.A. Review of Neuroscience. New York: Churchill Livingstone, 2003.
8. Ivry R.B., Spencer R.M. The neural representation of time. Curr Opin Neurobiol 14:225, 2004.
9. Janig W., Baron R. Complex regional pain syndrome: mystery explained? Lancet Neurol 2:687, 2003.
10. Jeannerod M. The mechanism of self-recognition in humans. Behav Brain Res 142:1, 2003.
11. Johnson К.О. The roles and functions of cutaneous mechano-receptors. Curr Opin Neurobiol 11:455, 2001.
12. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
13. Lumb B.M. Hypothalamic and midbrain circuitry that distinguishes between escapable and inescapable pain. News Physiol Sci 19:22, 2004.
14. Maravita A., Spence C., Driver J. Multisensory integration and the body schema: close to hand and within reach. Curr Biol 13:R531, 2003.
15. Pears S., Jackson S.R. Cognitive neuroscience: vision and touch are constant companions. Curr Biol 14:R349, 2004.
16. Petersen C.C. The barrel cortex-integrating molecular, cellular and systems physiology. Pflugers Arch 447:126, 2003.
17. Pouget A., Deneve S., Duhamel J.R. A computational perspective on the neural basis of multisensory spatial representations. Nat Rev Neurosci 3:741, 2002.
18. Sommer M.A. The role of the thalamus in motor control. Curr Opin Neurobiol 13:663, 2003.
19. Suga N., Ma X. Multiparametric corticofugal modulation and plasticity in the auditory system. Nat Rev Neurosci 4:783, 2003.
20. Thaut M.H. Neural basis of rhythmic timing networks in the human brain. Ann N Y Acad Sci 999:364, 2003.

1. Almeida T.F., Roizenblatt S., Tufik S. Afferent pain pathways: a neuroanatomical review. Brain Res 1000:40, 2004.
2. Ballantyne J.C., Mao J. Opioid therapy for chronic pain. N Engl J Med 349:1943, 2003.
3. Borsook D., Becerra L. Pain imaging: future applications to integrative clinical and basic neurobiology. Adv Drug Deliv Rev 55:967, 2003.
4. Bromm B. Brain images of pain. News Physiol Sci 16:244, 2001.
5. Bruera E., Kim H.N. Cancer pain. JAMA 290:2476, 2003.
6. Cervero F., Laird J.M. Role of ion channels in mechanisms controlling gastrointestinal pain pathways. Curr Opin Pharmacol 3:608, 2003.
7. Costigan M., Woolf C.J. No DREAM, no pain: closing the spinal gate. Cell 108:297, 2002.
8. Gebhart G.F. Descending modulation of pain. Neurosci Biob-ehav Rev 27:729, 2004.
9. Haines D.E. Fundamental Neuroscience. New York: Churchill Livingstone, 1997.
10. Haines D.E., Lancon J.A. Review of Neuroscience. New York: Churchill Livingstone, 2003.
11. Jordt S.E., McKemy D.D., Julius D. Lessons from peppers and peppermint: the molecular logic of thermosensation. Curr Opin Neurobiol 13:487, 2003.
12. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
13. Kors E.E., Vanmolkot K.R., Haan J. et al. Recent findings in headache genetics. Curr Opin Neurol 17:283, 2004.
14. Mendell J.R., Sahenk Z. Clinical practice: painful sensory neuropathy. N Engl J Med 348:1243, 2003.
15. Montell C. Thermosensation: hot findings make TRPNs very cool. Curr Biol 13:R476, 2003.
16. Sanchez-del-Rio M., Reuter U. Migraine aura: new information on underlying mechanisms. Curr Opin Neurol 17:289, 2004.
17. Schaible H.G., Ebersberger A., Von Banchet G.S. Mechanisms of pain in arthritis. Ann N Y Acad Sci 966:343, 2002.
18. Silberstein S.D. Migraine. Lancet 363:381, 2004.
19. Vogt B.A. Knocking out the DREAM to study pain. N Engl J Med 347:362, 2002.
20. Watkins L.R., Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82:981, 2002.
21. Zubrzycka M., Janecka A. Substance P: transmitter of nociception (minireview). Endocr Regul 34:195, 2000.

1. Buisseret Р. Influence of extraocular muscle proprioception on vision. Physiol Rev 75:323, 1995.
2. Congdon N.G., Friedman D.S., Lietman T. Important causes of visual impairment in the world today. JAMA 290:2057, 2003.
3. Corbett J.J. The bedside and office neuro-ophthalmology examination. Semin Neurol 23:63, 2003.
4. Doane J.F. Accommodating intraocular lenses. Curr Opin Ophthalmol 15:16, 2004.
5. Farr A.K., Guyton D.L. Strabismus after retinal detachment surgery. Curr Opin Ophthalmol 11:207, 2000.
6. Gilmartin B. Myopia: precedents for research in the twenty-first century. Clin Exp Ophthalmol 32:305, 2004.
7. Guyton D.L. Sights and Sounds in Ophthalmology: Ocular Motility and Binocular Vision. St Louis: CV Mosby, 1989.
8. Khaw P.T., Shah P., Elkington A.R. Glaucoma-1: diagnosis. BMJ 328:97, 2004.
9. Krag S., Andreassen T.T. Mechanical properties of the human lens capsule. Prog Retin Eye Res 22:749, 2003.
10. Mathias R.T., Rae J.L., Baldo G.J. Physiological properties of the normal lens. Physiol Rev 77:21, 1997.
11. McBrien N.A., Gentle A. Role of the sclera in the development and pathological complications of myopia. Prog Retin Eye Res 22:307, 2003.
12. O’Shea J., Walsh V. Visual awareness: the eye fields have it? Curr Biol 14.-R279, 2004.
13. Schaeffel F., Simon P., Feldkaemper M. et al. Molecular biology of myopia. Clin Exp Optom 86:295, 2003.
14. Schwartz K., Budenz D. Current management of glaucoma. Curr Opin Ophthalmol 15:119, 2004.
15. Smith G. The optical properties of the crystalline lens and their significance. Clin Exp Optom 86:3, 2003.
16. Smith G., Atchison D.A. The Eye and Visual Optical Instruments. Cambridge: Cambridge University Press, 1997.
17. Weinreb R.N., Khaw P.T. Primary open-angle glaucoma. Lancet 363:1711, 2004.

1. Arshavsky V. Like night and day: rods and cones have different pigment regeneration pathways. Neuron 36:1, 2002.
2. Backharis W., Kliegl R., Werner J.S. Color Vision. Berlin: Walter de Gruyter, 1998.
3. Berger J.W., Fine S.L., Maguire M.G. Age-Related Macular Degeneration. St Louis: Mosby, 1999.
4. Berson D.M. Strange vision: ganglion cells as circadian photoreceptors. Trends Neurosci 26:314, 2003.
5. Burr D., Ross J. Vision: the world through picket fences. Curr Biol 14:R381, 2004.
6. Calkins D.J. Seeing with S cones. Prog Retin Eye Res 20:255, 2001.
7. Dacey D.M., Packer O.S. Colour coding in the primate retina: diverse cell types and cone-specific circuitry. Curr Opin Neurobiol 13:421, 2003.
8. Fain G.L., Matthews H.R., Cornwall M.C., Koutalos Y. Adaptation in vertebrate photoreceptors. Physiol Rev 81:117, 2001.
9. Garriga P., Manyosa J. The eye photoreceptor protein rhodo-psin: structural implications for retinal disease. FEBS Lett 528:17, 2002.
10. Gegenfurtner K.R. Cortical mechanisms of colour vision. Nat Rev Neurosci 4:563, 2003.
11. Gegenfurtner K.R., Kiper D.C. Color vision. Annu Rev Neurosci 26:181, 2003.
12. Hardie R.C. Phototransduction: shedding light on translocation. Curr Biol 13:R775, 2003.
13. Hendee W.A., Wells P.N.T. The Perception of Visual Information. New York: Springer, 1997.
14. Kolb H., Nelson R., Ahnelt P., Cuenca N. Cellular organization of the vertebrate retina. Prog Brain Res 131:3, 2001.
15. Masland R.H. The fundamental plan of the retina. Nat Neurosci 4:877, 2001.
16. Michaelides M., Hunt D.M., Moore A.T. The cone dysfunction syndromes. Br J Ophthalmol 88:291, 2004.
17. Neitz M., Neitz J. Molecular genetics of color vision and color vision defects. Arch Ophthalmol 118:691, 2000.
18. Schwartz E.A. Transport-mediated synapses in the retina. Physiol Rev 82:875, 2002.
19. Taylor W.R., Vaney D.I. New directions in retinal research. Trends Neurosci 26:379, 2003.
20. Thompson D.A., Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog Retin Eye Res 22:683, 2003.
21. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122:598, 2004.

1. Backharis W., Kliegl R., Werner J.S. Color Vision. Berlin: Walter de Gruyter, 1998.
2. Becker W., Reubel H., Mergner T. Current Oculomotor Research. New York: Plenum Press, 1999.
3. Burr D. Eye movements: keeping vision stable. Curr Biol 14:R195, 2004.
4. Buttner-Ennever J.A., Eberhorn A., Horn A.K. Motor and sensory innervation of extraocular eye muscles. Ann N Y Acad Sci 1004:40, 2003.
5. Chalupa L.M., Gunhan E. Development of on and off retinal pathways and retinogeniculate projections. Prog Retin Eye Res 23:31, 2004.
6. Crawford J.D., Martinez-Trujillo J.C., Klier E.M. Neural control of three-dimensional eye and head movements. Curr Opin Neurobiol 13:655, 2003.
7. Dacey D.M. Parallel pathways for spectral coding in primate retina. Annu Rev Neurosci 23:743, 2000.
8. Demer J.L. The orbital pulley system: a revolution in concepts of orbital anatomy. Ann N Y Acad Sci 956:17, 2002.
9. Derrington A.M., Webb B.S. Visual system: how is the retina wired up to the cortex? Curr Biol 14:R14, 2004.
10. Ferster D., Miller K.D. Neural mechanisms of orientation selectivity in the visual cortex. Annu Rev Neurosci 23:441, 2000.
11. Hendee W.A., Wells P.N.T. The Perception of Visual Information. New York: Springer, 1997.
12. Hikosaka O., Takikawa Y., Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 80:953, 2000.
13. Kastner S., Ungerleider L.G. Mechanisms of visual attention in the human cortex. Annu Rev Neurosci 23:315, 2000.
14. Krauzlis R.J. Recasting the smooth pursuit eye movement system. J Neurophysiol 91:591, 2004.
15. Leigh R.J., Lee D.S. The Neurology of Eye Movements. New York: Oxford University Press, 1999.
16. Mante V., Carandini M. Visual cortex: seeing motion. Curr Biol 13:R906, 2003.
17. Martinez-Conde S., Macknik S.L., Hubei D.H. The role of fi-xational eye movements in visual perception. Nat Rev Neurosci 5:229, 2004.
18. Munoz D.P., Everling S. Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci 5:218, 2004.
19. Pierrot-Deseilligny C, Milea D., Muri R.M. Eye movement control by the cerebral cortex. Curr Opin Neurol 17:17, 2004.
20. Treue S. Visual attention: the where, what, how and why of sa-liency. Curr Opin Neurobiol 13:428, 2003.
21. van Wezel R.J., van der Smagt M.J. Motion processing: how low can you go? Curr Biol 13:R840, 2003.

1. Brugge J. Central Auditory Processing and Neural Modeling. New York: Plenum Press, 1998.
2. Eatock R.A. Auditory physiology: listening with K+ channels. Curr Biol 13:R767, 2003.
3. Fettiplace R., Ricci A.J. Adaptation in auditory hair cells. Curr Opin Neurobiol 13:446, 2003.
4. Frolenkov G.I., Belyantseva I.A., Friedman T.B., Griffith A.J. Genetic insights into the morphogenesis of inner ear hair cells. Nat Rev Genet 5:489, 2004.
5. Geisler C.D. From Sound to Synapse: Physiology of the Mammalian Ear. New York: Oxford University Press, 1998.
6. Gillespie P.G., Cyr J.L. Myosin-lc, the hair cell’s adaptation motor. Annu Rev Physiol 66:521, 2004.
7. Griffiths T.D., Warren J.D., Scott S.K. et al. Cortical processing of complex sound: a way forward? Trends Neurosci 27:181, 2004.
8. Grothe B. New roles for synaptic inhibition in sound localization. Nat Rev Neurosci 4:540, 2003.
9. Joris P.X., Schreiner C.E., Rees A. Neural processing of amplitude-modulated sounds. Physiol Rev 84:541, 2004.
10. McDermott B.M. Jr., Lopez-Schier H. Inner ear: Ca2+ you feel the noise? Curr Biol 14:R231, 2004.
11. Minor L.B., Schessel D.A., Carey J.P. Meniere’s disease. Curr Opin Neurol 17:9, 2004.
12. Rauschecker J.P., Shannon R.V. Sending sound to the brain. Science 295:1025, 2002.
13. Read H.L., Winer J.A., Schreiner C.E. Functional architecture of auditory cortex. Curr Opin Neurobiol 12:433, 2002.
14. Robles L., Ruggero M.A. Mechanics of the mammalian cochlea. Physiol Rev 81:1305, 2001.
15. Santos-Sacchi J. New tunes from Corti’s organ: the outer hair cell boogie rules. Curr Opin Neurobiol 13:459, 2003.
16. Schreiner C.E., Read H.L., Sutter M.L. Modular organization of frequency integration in primary auditory cortex. Annu Rev Neurosci 23:501, 2000.
17. Scott S.K., Johnsrude I.S. The neuroanatomical and functional organization of speech perception. Trends Neurosci 26:100, 2003.
18. Semple M.N., Scott B.H. Cortical mechanisms in hearing. Curr Opin Neurobiol 13:167, 2003.
19. Suga N., Ma X. Multiparametric corticofugal modulation and plasticity in the auditory system. Nat Rev Neurosci 4:783, 2003.
20. Syka J. Plastic changes in the central auditory system after hearing loss, restoration of function, and during learning. Physiol Rev 82:601,2002.
21. Trainor L.J., Shahin A., Roberts L.E. Effects of musical training on the auditory cortex in children. Ann N Y Acad Sci 999:506, 2003.
22. Weinberger N.M. Specific long-term memory traces in primary auditory cortex. Nat Rev Neurosci 5:279, 2004.

1. Bermudez-Rattoni F. Molecular mechanisms of taste-recognition memory. Nat Rev Neurosci 5:209, 2004.
2. Dohlman H.G. G proteins and pheromone signaling. Annu Rev Physiol 64:129, 2002.
3. Gibson A.D., Garbers D.L. Guanylyl cyclases as a family of putative odorant receptors. Annu Rev Neurosci 23:417, 2000. Herness M.S., Gilbertson T.A. Cellular mechanisms of taste transduction. Annu Rev Physiol 61:873, 1999.
4. Levine A.S., Kotz C.M., Gosnell B.A. Sugars and fats: the neurobiology of preference. J Nutr 133:83IS, 2003.
5. Lledo P.M., Gheusi G. Olfactory processing in a changing brain. Neuroreport 14:1655, 2003.
6. Lowe G. Electrical signaling in the olfactory bulb. Curr Opin Neurobiol 13:476, 2003.
7. Margolskee R.F. Molecular mechanisms of bitter and sweet taste transduction. J Biol Chem 277:1, 2002.
8. Matthews H.R., Reisert J. Calcium, the two-faced messenger of olfactory transduction and adaptation. Curr Opin Neurobiol 13:469, 2003.
9. Menini A., Lagostena L., Boccaccio A. Olfaction: from odorant molecules to the olfactory cortex. News Physiol Sci 19:101, 2004.
10. Mombaerts P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat Rev Neurosci 5:263, 2004.
11. Mombaerts P. Odorant receptor gene choice in olfactory sensory neurons: the one receptor-one neuron hypothesis revisited. Curr Opin Neurobiol 14:31, 2004.
12. Montmayeur J.P., Matsunami H. Receptors for bitter and sweet taste. Curr Opin Neurobiol 12:366, 2002.
13. Reed R.R. The contribution of signaling pathways to olfactory organization and development. Curr Opin Neurobiol 13:482, 2003.
14. Ronnett G.V., Moon C. G proteins and olfactory signal transduction. Annu Rev Physiol 64:189, 2002.
15. Sewards T.V. Dual separate pathways for sensory and hedonic aspects of taste. Brain Res Bull 62:271, 2004.
16. Smith D.V., Margolskee R.F. Making sense of taste. Sci Am 284:32, 2001.

1. Buffelli М., Busetto G., Bidoia С. et al. Activity-dependent synaptic competition at mammalian neuromuscular junctions. News Physiol Sci 19:85, 2004.
2. Chen H.H., Hippenmeyer S., Arber S., Frank E. Development of the monosynaptic stretch reflex circuit. Curr Opin Neuro-biol 13:96, 2003.
3. Dietz V. Proprioception and locomotor disorders. Nat Rev Neurosci 3:781, 2002.
4. Dietz V. Spinal cord pattern generators for locomotion. Clin Neurophysiol 114:1379, 2003.
5. Dobkin B.H., Havton L.A. Basic advances and new avenues in therapy of spinal cord injury. Annu Rev Med 55:255, 2004.
6. Duysens J., Clarac F., Cruse H. Load-regulating mechanisms in gait and posture: comparative aspects. Physiol Rev 80:83,2000.
7. Garwicz M. Spinal reflexes provide motor error signals to cerebellar modules — relevance for motor coordination. Brain Res Brain Res Rev 40:152, 2002.
8. Glover J.C. Development of specific connectivity between premotor neurons and motoneurons in the brain stem and spinal cord. Physiol Rev 80:615, 2000.
9. Grillner S. The motor infrastructure: from ion channels to neuronal networks. Nat Rev Neurosci 4:573, 2003.
10. Grillner S. Muscle twitches during sleep shape the precise muscles of the withdrawal reflex. Trends Neurosci 27:169, 2004.
11. Guthrie S. Neuronal development: putting motor neurons in their place. Curr Biol 14:R166, 2004.
12. Haines D.E. Fundamental Neuroscience. New York: Churchill Livingstone, 1997.
13. Haines D.E., Lancon J.A. Review of Neuroscience. New York: Churchill Livingstone, 2003.
14. Helms A.W., Johnson J.E. Specification of dorsal spinal cord interneurons. Curr Opin Neurobiol 13:42, 2003.
15. Jankowska E. Spinal interneuronal systems: identification, multifunctional character and reconfigurations in mammals. J Physiol 533:31, 2001.
16. Jankowska E., Hammar I. Spinal interneurons: how can studies in animals contribute to the understanding of spinal interneuronal systems in man? Brain Res Brain Res Rev 40:19, 2002.
17. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
18. Marder E., Bucher D. Central pattern generators and the control of rhythmic movements. Curr Biol 11:R986, 2001.
19. Marder E., Prinz A.A. Current compensation in neuronal homeostasis. Neuron 37:2, 2003.
20. Pearson K.G. Generating the walking gait: role of sensory feedback. Prog Brain Res 143:123, 2004.
21. Rekling J.C., Funk G.D., Bayliss D.A. et al. Synaptic control of motoneuronal excitability. Physiol Rev 80:767, 2000.
22. Rossignol S., Bouyer L., Barthelemy D. et al. Recovery of locomotion in the cat following spinal cord lesions. Brain Res Brain Res Rev 40:257, 2002.

1. Alitto Н.J., Usrey W.M. Corticothalamic feedback and sensory processing. Curr Opin Neurobiol 13:440, 2003.
2. Angelaki D.E., Dickman J.D. Gravity or translation: central processing of vestibular signals to detect motion or tilt. J Vestib Res 13:245, 2003.
3. Barmack N.H. Central vestibular system: vestibular nuclei and posterior cerebellum. Brain Res Bull 60:511, 2003.
4. Blake D.T., Byl N.N., Merzenich M.M. Representation of the hand in the cerebral cortex. Behav Brain Res 135:179, 2002.
5. Boyle R. Vestibulospinal control of reflex and voluntary head movement. Ann N Y Acad Sci 942:364, 2001.
6. Cullen K.E., Roy J.E. Signal processing in the vestibular system during active versus passive head movements. J Neurophysiol 91:1919, 2004.
7. Garwicz M. Spinal reflexes provide motor error signals to cerebellar modules — relevance for motor coordination. Brain Res Brain Res Rev 40:152, 2002.
8. Johansen-Berg H. Motor physiology: a brain of two halves. Curr Biol 13:R802, 2003.
9. Raineteau O., Schwab M.E. Plasticity of motor systems after incomplete spinal cord injury. Nat Rev Neurosci 2:263, 2001.
10. Raphael Y., Altschuler R.A. Structure and innervation of the cochlea. Brain Res Bull 60:397, 2003.
11. Robles L., Ruggero M.A. Mechanics of the mammalian cochlea. Physiol Rev 81:1305, 2001.
12. Salenius S., Hari R. Synchronous cortical oscillatory activity during motor action. Curr Opin Neurobiol 13:678, 2003.
13. Sanes J.N. Neocortical mechanisms in motor learning. Curr Opin Neurobiol 13:225, 2003.
14. Schieber M.H. Motor control: basic units of cortical output? Curr Biol 14:R353, 2004.
15. Scott S.H. The role of primary motor cortex in goal-directed movements: insights from neurophysiological studies on non-human primates. Curr Opin Neurobiol 13:671, 2003.
16. Umilta M.A. Frontal cortex: goal-relatedness and the cortical motor system. Curr Biol 14:R204, 2004.
17. Yates B.J., Miller A.D., Lucot J.B. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 47:395, 1998.

1. Albin R.L. Dominant ataxias and Friedreich ataxia: an update. Curr Opin Neurol 16:507, 2003.
2. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205, 2004. Brooks V.B., Thach W.T. Cerebellar control of posture and movement. In: Handbook of Physiology, Sec. 1, Vol. II. Bethes-da: American Physiological Society, 1981, p. 877.
3. DeKosky S.T., Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science 302:830, 2003.
4. de Zeeuw C.I., Strata P., Voogd J. The Cerebellum: From Structure to Control. Amsterdam: Elsevier, 1997.
5. Elble R.J. Origins of tremor. Lancet 355:1113, 2000.
6. Garwicz M., Ekerot C.-F., Jorntell H. Organizational principles of cerebellar neuronal circuitry. News Physiol Sci 13:26,1998. Gibson A.R., Horn K.M., Pong M. Inhibitory control of olivary discharge. Ann N Y Acad Sci 978:219, 2002.
7. Goodale M.A., Westwood D.A. An evolving view of duplex vision: separate but interacting cortical pathways for perception and action. Curr Opin Neurobiol 14:203, 2004.
8. Ito M. Cerebellar long-term depression: characterization, signal transduction, and functional roles. Physiol Rev 81:1143, 2001.
9. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
10. Keifer J., Houk J.C. Motor function of the cerebellorubrospinal system. Physiol Rev 74:509, 1994.
11. Li J.Y., Plomann M., Brundin P. Huntington’s disease: a synap-topathy? Trends Mol Med 9:414, 2003.
12. Obeso J.A., Rodriguez-Oroz M., Marin C. et al. The origin of motor fluctuations in Parkinson’s disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 62 (1 Suppl 1 ):S 17, 2004.
13. Ohyama T., Medina J.F., Nores W.L., Mauk M.D. Trying to understand the cerebellum well enough to build one. Ann N Y Acad Sci 978:425, 2002.
14. Olanow C.W. The scientific basis for the current treatment of Parkinson’s disease. Annu Rev Med 55:41, 2004.
15. Samii A., Nutt J.G., Ransom B.R. Parkinson’s disease. Lancet 363:1783, 2004.
16. Schweighofer N., Doya K., Kuroda S. Cerebellar aminergic neuromodulation: towards a functional understanding. Brain Res Brain Res Rev 44:103, 2004.
17. Sethi K.D. Tremor. Curr Opin Neurol 16:481, 2003.

1. Baddeley A. Working memory: looking back and looking forward. Nat Rev Neurosci 4:829, 2003.
2. Blank T., Nijholt I., Spiess J. Molecular determinants mediating effects of acute stress on hippocampus-dependent synaptic plasticity and learning. Mol Neurobiol 29:131, 2004. Bookheimer S. Functional MRI of language: new approaches to understanding the cortical organization of semantic processing. Annu Rev Neurosci 25:151, 2002.
3. Conlon R., Hobson J.A. Understanding the Human Mind. New York: John Wiley, 1999.
4. Dash P.K., Hebert A.E., Runyan J.D. A unified theory for systems and cellular memory consolidation. Brain Res Brain Res Rev 45:30, 2004.
5. Dick P., Katsuyuki S. The prefrontal cortex and working memory: physiology and brain imaging. Curr Opin Neurobiol 14:163, 2004.
6. Dudai Y. The neurobiology of consolidations, or, how stable is the engram? Annu Rev Psychol 55:51, 2004.
7. Ehrlich Y.M. Molecular and Cellular Mechanisms of Neuronal Plasticity. New York: Plenum Press, 1998.
8. Guillery R.W. Branching thalamic afferents link action and perception. J Neurophysiol 90:539, 2003.
9. Haines D.E. Fundamental Neuroscience. New York: Churchill Livingstone, 1997.
10. Hamann S., Canli T. Individual differences in emotion processing. Curr Opin Neurobiol 14:233, 2004.
11. Kandel E.R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294:1030, 2001.
12. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
13. LeDoux J.E. Emotion, memory and the brain: the neural routes underlying the formation of memories about primitive emotional experiences, such as fear, have been traced. Sci Am June: 50, 1994.
14. Leuner B., Shors T.J. New spines, new memories. Mol Neurobiol 29:117, 2004.
15. Lynch M.A. Long-term potentiation and memory. Physiol Rev 84:87, 2004.
16. Miller B.L., Cummings J.L. The Human Frontal Lobes. New York: Guilford Press, 1998.
17. Nakazawa K., McHugh T.J., Wilson M.A., Tonegawa S. NMDA receptors, place cells and hippocampal spatial memory. Nat Rev Neurosci 5:361, 2004.
18. Phelps E.A. Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol 14:198, 2004.
19. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 83:803, 2003.
20. Shors T.J. Memory traces of trace memories: neurogenesis, synaptogenesis and awareness. Trends Neurosci 27:250, 2004.
21. Wixted J.T. The psychology and neuroscience of forgetting. Annu Rev Psychol 55:235, 2004.

1. Adell A., Celada Р., Abelian М.Т., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res Brain Res Rev 39:154, 2002.
2. Bechara A., Damasio H., Damasio A.R. Role of the amygdala in decision-making. Ann N Y Acad Sci 985:356, 2003.
3. Blank T., Nijholt I., Spiess J. Molecular determinants mediating effects of acute stress on hippocampus-dependent synaptic plasticity and learning. Mol Neurobiol 29:131, 2004.
4. Bouret S.G., Simerly R.B. Leptin and development of hypothalamic feeding circuits. Endocrinology 145:2621, 2004.
5. Conlon R., Hobson J.A. Understanding the Human Mind. New York: John Wiley, 1999.
6. Denton D.A., McKinley M.J., Weisinger R.S. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci USA 93:7397, 1996.
7. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 985:420, 2003.
8. Gerashchenko D., Shiromani P.J. Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness. Mol Neurobiol 29:41, 2004.
9. Guillery R.W. Branching thalamic afferents link action and perception. J Neurophysiol 90:539, 2003.
10. Haines D.E. Fundamental Neuroscience. New York: Churchill Livingstone, 1997.
11. Holland P.C., Gallagher M. Amygdala — frontal interactions and reward expectancy. Curr Opin Neurobiol 14:148, 2004.
12. Joels M., Verkuyl J.M., Van Riel E. Hippocampal and hypothalamic function after chronic stress. Ann N Y Acad Sci 1007:367, 2003.
13. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of Neural Science, 4th ed. New York: McGraw-Hill, 2000.
14. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neuros-ci Biobehav Rev 27:765, 2004.
15. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 23:155, 2000.
16. Lumb B.M. Hypothalamic and midbrain circuitry that distinguishes between escapable and inescapable pain. News Physiol Sci 19:22, 2004.
17. Morris J.F., Ludwig M. Magnocellular dendrites: prototypic re-ceiver/transmitters. J Neuroendocrinol 16:403, 2004.
18. Phelps E.A. Human emotion and memory: interactions of the amygdala and hippocampal complex. Curr Opin Neurobiol 14:198, 2004.
19. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 83:803, 2003.
20. van den Pol A.N. Weighing the role of hypothalamic feeding neurotransmitters. Neuron 40:1059, 2003.
21. Vann S.D., Aggleton J.P. The mammillary bodies: two memory systems in one? Nat Rev Neurosci 5:35, 2004.
22. Wild B., Rodden F.A., Grodd W., Ruch W. Neural correlates of laughter and humour. Brain 126:2121, 2003.

1. Aldrich M.S. Sleep Medicine: Normal Sleep and Its Disorders. New York: Oxford University Press, 1999.
2. Beardsley T. Waking up. Sci Am Jul 18, 1996.
3. Bryant P.A., Trinder J., Curtis N. Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol 4:457, 2004.
4. Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139, 2004.
5. Cummings J.L. Alzheimer’s disease. N Engl J Med 351:56, 2004.
6. De la Torre J.C. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3:184, 2004.
7. George A.L. Jr. Molecular basis of inherited epilepsy. Arch Neurol 61:473, 2004.
8. Gerashchenko D., Shiromani P.J. Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness. Mol Neurobiol 29:41, 2004.
9. Golde T.E. Alzheimer disease therapy: can the amyloid cascade be halted? J Clin Invest 111:11, 2003.
10. Gourfinkel-An I., Baulac S., Nabbout R. et al. Monogenic idiopathic epilepsies. Lancet Neurol 3:209, 2004.
11. Greene R., Siegel J. Sleep: a functional enigma. Neuromolecular Med 5:59, 2004.
12. Heller H.C., Ruby N.F. Sleep and circadian rhythms in mammalian torpor. Annu Rev Physiol 66:275, 2004.
13. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci 5:347-360, 2004.
14. LaRoche S.M., Helmers S.L. The new antiepileptic drugs: scientific review. JAMA 291:605, 2004.
15. McCormick D.A., Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 63:815, 2001.
16. Noebels J.L. The biology of epilepsy genes. Annu Rev Neurosci 26:599, 2003.
17. Selkoe D.J. Alzheimer disease: mechanistic understanding predicts novel therapies. Ann Intern Med 140:627, 2004.
18. Selkoe D.J. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741, 2001.
19. Steinlein O.K. Genetic mechanisms that underlie epilepsy. Nat Rev Neurosci 5:400-408, 2004.

1. Andresen М.С., Doyle M.W., Jin Y.H., Bailey T.W. Cellular mechanisms of baroreceptor integration at the nucleus trac-tus solitarius. Ann N Y Acad Sci 940:132, 2001.
2. Chang H.Y., Mashimo H., Goyal R.K. Musings on the wanderer: what’s new in our understanding of vago-vagal reflex? IV. Current concepts of vagal efferent projections to the gut. Am J Physiol Gastrointest Liver Physiol 284:G357, 2003.
3. Dajas-Bailador F., Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25:317, 2004.
4. Dampney R.A., Horiuchi J., Tagawa T. et al. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 177:209, 2003.
5. DiBona G.F., Kopp U.C. Neural control of renal function. Physiol Rev 77:75, 1997.
6. Gibbins I.L., Jobling P., Morris J.L. Functional organization of peripheral vasomotor pathways. Acta Physiol Scand 177:237, 2003.
7. Goldstein D.S. Catecholamines and stress. Endocr Regul 37:69, 2003.
8. Goldstein D.S., Robertson D., Esler M. et al. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 137:753, 2002.
9. Hall J.E., Hildebrandt D.A., Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens 14:103S, 2001.
10. Hirst G.D., Ward S.M. Interstitial cells: involvement in rhythmi-city and neural control of gut smooth muscle. J Physiol 550:337, 2003.
11. Koch W.J., Lefkowitz R.J., Rockman H.A. Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol 62:237, 2000.
12. Lefkowitz R.J., Rockman H.A., Koch W.J. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 101:1634, 2000.
13. Lohmeier T.E. The sympathetic nervous system and long-term blood pressure regulation. Am J Hypertens 14:147S, 2001.
14. Saper C.B. The central autonomic nervous system: conscious visceral perception and autonomic pattern generation. Annu Rev Neurosci 25:433, 2002.
15. Taylor E.W., Jordan D., Coote J.H. Central control of the cardiovascular and respiratory systems and their interactions in vertebrates. Physiol Rev 79:855, 1999.
16. Wanamaker C.P., Christianson J.C., Green W.N. Regulation of nicotinic acetylcholine receptor assembly. Ann N Y Acad Sci 998:66, 2003.
17. Wess J. Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol Sci 24:414, 2003.

1. Anderson С.М., Nedergaard М. Astrocyte-mediated control of cerebral microcirculation. Trends Neurosci 26:340, 2003.
2. Antunes-Rodrigues J., de Castro M., Elias L.L. et al. Neuroendocrine control of body fluid metabolism. Physiol Rev 84:169, 2004.
3. Burmester T., Hankeln T. Neuroglobin: a respiratory protein of the nervous system. News Physiol Sci 19:110, 2004.
4. Chesler M. Regulation and modulation of pH in the brain. Physiol Rev 83:1183, 2003.
5. Duelli R., Kuschinsky W. Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16:71, 2001.
6. Faraci F.M. Vascular protection. Stroke 34:327, 2003.
7. Faraci F.M., Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78:53, 1998.
8. Ganong W.F. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 27:422, 2000.
9. Gore J.C. Principles and practice of functional MRI of the human brain. J Clin Invest 112:4, 2003.
10. Harder D.R., Zhang C., Gebremedhin D. Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci 17:27, 2002.
11. Johnston M., Papaiconomou C. Cerebrospinal fluid transport: a lymphatic perspective. News Physiol Sci 17:227, 2002.
12. Logothetis N.K., Wandell B.A. Interpreting the BOLD signal. Annu Rev Physiol 66:735, 2004.
13. Nadareishvili Z., Hallenbeck J. Neuronal regeneration after stroke. N Engl J Med 348:2355, 2003.
14. Osborn J.W., Collister J.P., Carlson S.H. Angiotensin and osmoreceptor inputs to the area postrema: role in long-term control of fluid homeostasis and arterial pressure. Clin Exp Pharmacol Physiol 27:443, 2000.
15. Pardridge W.M. An Introduction to the Blood-Brain Barrier. Cambridge: Cambridge University Press, 1998.
16. Paulson O.B. Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol 12:495, 2002.
17. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82:131, 2002.
18. Roth J., Harre E.M., Rummel C. et al. Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front Biosci 9:290, 2004.

1. Adelson D.W., Million М. Tracking the moveable feast: sono-micrometry and gastrointestinal motility. News Physiol Sci 19:27, 2004.
2. Daniel E.E. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside. III. Interaction of interstitial cells of Cajal with neuromediators: an interim assessment. Am J Physiol Gastrointest Liver Physiol 281:G1329, 2001.
3. Furness J.B., Jones C., Nurgali K., Clerc N. Intrinsic primary afferent neurons and nerve circuits within the intestine. Prog Neurobiol 72:143, 2004.
4. Hansen M.B. The enteric nervous system II: gastrointestinal functions. Pharmacol Toxicol 92:249-57, 2003.
5. Hobson A.R., Aziz Q. Central nervous system processing of human visceral pain in health and disease. News Physiol Sci 18:109, 2003.
6. Hocker M. Molecular mechanisms of gastrin-dependent gene regulation. Ann N Y Acad Sci 1014:97, 2004.
7. Huizinga J.D. Physiology and pathophysiology of the interstitial cell of Cajal: from bench to bedside. II. Gastric motility: lessons from mutant mice on slow waves and innervation. Am J Physiol Gastrointest Liver Physiol 281:G1129, 2001. Inui A., Asakawa A., Bowers C.Y. et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 18:439, 2004.
8. Johnson L.R. Gastrointestinal Physiology, 6th ed. St. Louis: Mosby, 2001.
9. Lammers W.J., Slack J.R. Of slow waves and spike patches. News Physiol Sci 16:138, 2001.
10. Moran T.H., Kinzig K.P. Gastrointestinal satiety signals II. Cho-lecystokinin. Am J Physiol Gastrointest Liver Physiol 286:G183, 2004.
11. Powley T.L., Phillips R.J. Musings on the wanderer: what’s new in our understanding of vago-vagal reflexes? I. Morphology and topography of vagal afferents innervating the GI tract. Am J Physiol Gastrointest Liver Physiol 283:G1217, 2002. Rehfeld J.F. The new biology of gastrointestinal hormones. Physiol Rev 78:1087, 1998.
12. Sanders K.M., Ordog T., Ward S.M. Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal. Am J Physiol Gastrointest Liver Physiol 282:G747, 2002.
13. Smith G.P. Satiation: From Gut to Brain. New York: Oxford University Press, 1998.
14. Thomas R.P., Hellmich M.R., Townsend C.M. Jr., Evers B.M. Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. Endocr Rev 24:571, 2003.
15. Woods S.C. Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol 286:G7, 2004.

1. Adelson D.W., Million М. Tracking the moveable feast: sono-micrometry and gastrointestinal motility. News Physiol Sci 19:27, 2004.
2. Chelimsky G., Chelimsky T.C. Evaluation and treatment of autonomic disorders of the gastrointestinal tract. Semin Neurol 23:453, 2003.
3. Cooke H.J., Wunderlich J., Christofi F.L. «The force be with you»: ATP in gut mechanosensory transduction. News Physiol Sci 18:43, 2003.
4. De Giorgio R., Guerrini S., Barbara G. et al. Inflammatory neuropathies of the enteric nervous system. Gastroenterology 126:1872, 2004.
5. Gonella J., Bouvier M., Blanquet F. Extrinsic nervous control of motility of small and large intestines and related sphincters. Physiol Rev 67:902, 1987.
6. Hall K.E. Aging and neural control of the GI tract. II. Neural control of the aging gut: can an old dog learn new tricks? Am J Physiol Gastrointest Liver Physiol 283:G827, 2002.
7. Hansen M.B. Neurohumoral control of gastrointestinal motility. Physiol Res 52:1, 2003.
8. Hatoum O.A., Miura H., Binion D.G. The vascular contribution in the pathogenesis of inflammatory bowel disease. Am J Physiol Heart Circ Physiol 285:H1791, 2003.
9. Jensen R.T. Involvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders. Pharmacol Toxicol 91:333, 2002.
10. Johnson L.R. Gastrointestinal Physiology, 6th ed. St. Louis: Mosby, 2001.
11. Kirkup A.J., Brunsden A.M., Grundy D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol Gastrointest Liver Physiol 280:G787, 2001.
12. Laroux F.S., Pavlick K.P., Wolf R.E., Grisham M.B. Dysregula-tion of intestinal mucosal immunity: implications in inflammatory bowel disease. News Physiol Sci 16:272, 2001.
13. Orr W.C., Chen C.L. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am J Physiol Gastrointest Liver Physiol 283:G1226, 2002.
14. Rao S.S. Pathophysiology of adult fecal incontinence. Gastroenterology 126 (1 Suppl 1):S 14, 2004.
15. Sanders K.M., Ordog T., Koh S.D., Ward S.M. A Novel Pacemaker Mechanism Drives Gastrointestinal Rhythmicity. News Physiol Sci 15:291,2000.
16. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 38:421, 2003.
17. Timmons S., Liston R., Moriarty K.J. Functional dyspepsia: motor abnormalities, sensory dysfunction, and therapeutic options. Am J Gastroenterol 99:739, 2004.

1. Barrett К.Е., Keely S.J. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 62:535, 2000.
2. Chiang J.Y. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284:G349, 2003.
3. Dockray G.J., Varro A., Dimaline R. Gastric endocrine cells: gene expression, processing, and targeting of active products. Physiol Rev 76:767, 1996.
4. Dockray G.J., Varro A., Dimaline R., Wang T. The gastrins: their production and biological activities. Annu Rev Physiol 63:119, 2001.
5. Flemstrom G., Isenberg J.I. Gastroduodenal mucosal alkaline secretion and mucosal protection. News Physiol Sci 16:23, 2001.
6. Fuchs M. Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challenges. Am J Physiol Gastrointest Liver Physiol 284:G551, 2003.
7. Hocker M. Molecular mechanisms of gastrin-dependent gene regulation. Ann N Y Acad Sci 1014:97, 2004.
8. Jass J.R., Walsh M.D. Altered mucin expression in the gastrointestinal tract: a review. J Cell Mol Med 5:327, 2001.
9. Johnson L.R. Gastrointestinal Physiology, 6th ed. St. Louis: Mosby, 2001.
10. Kidd J.F., Thorn P. Intracellular Ca2+ and СГ channel activation in secretory cells. Annu Rev Physiol 62:493, 2000.
11. Lee M.G., Ahn W., Lee J.A., Kim J.Y. et al. Coordination of pancreatic НСОз- secretion by protein-protein interaction between membrane transporters. JOP 2(4 Suppl):203, 2001.
12. Marve G.M. Nerves and hormones interact to control gallbladder function. News Physiol Sci 13:64, 1998.
13. Portincasa P., Di Ciaula A., van Berge-Henegouwen G.P. Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep 6:151, 2004.
14. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72:137, 2003.
15. Tandler B., Gresik E.W., Nagato T., Phillips C.J. Secretion by striated ducts of mammalian major salivary glands: review from an ultrastructural, functional, and evolutionary perspective. Anat Rec 264:121, 2001.
16. Trauner M., Boyer J.L. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633,2003.
17. Williams J.A. Intracellular signaling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol 63:77, 2001.
18. Zanner R., Gratzl M., Prinz C. Circle of life of secretory vesicles in gastric enterochromaffin-like cells. Ann N Y Acad Sci 971:389, 2002.

1. Adibi S.A. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol Gastrointest Liver Physiol 285:G779, 2003.
2. Barrett K.E., Keely S.J. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol 62:535, 2000.
3. Daniel Н. Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66:361, 2004.
4. Farhadi A., Banan A., Fields J., Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 18:479, 2003.
5. Ferraris R.P., Diamond J. Regulation of intestinal sugar transport. Physiol Rev 77:257, 1997.
6. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 111:931, 2003.
7. Greig E., Sandle G.I. Diarrhea in ulcerative colitis. The role of altered colonic sodium transport. Ann N Y Acad Sci 915:327, 2000.
8. Hershberg R.M. The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 283.-G833, 2002.
9. Johnson L.R. Gastrointestinal Physiology, 6th ed. St. Louis: Mosby, 2001.
10. Kullak-Ublick G.A., Stieger B., Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322, 2004.
11. Kunzelmann K., Mall M. Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82:245, 2002.
12. Meier P.J., Stieger B. Bile salt transporters. Annu Rev Physiol 64:635, 2002.
13. Pacha J. Development of intestinal transport function in mammals. Physiol Rev 80:1633, 2000.
14. Pappenheimer J.R. Intestinal absorption of hexoses and amino acids: from apical cytosol to villus capillaries. J Membr Biol 184:233, 2001.
15. Peng J.B., Brown E.M., Hediger M.A. Apical entry channels in calcium-transporting epithelia. News Physiol Sci 18:158, 2003.
16. Reuss L. One-hundred years of inquiry: the mechanism of glucose absorption in the intestine. Annu Rev Physiol 62:939, 2000.
17. Rossier B.C., Pradervand S., Schild L., Hummler E. Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors. Annu Rev Physiol 64:877, 2002.
18. Rothman S., Liebow C., Isenman L. Conservation of digestive enzymes. Physiol Rev 82:1, 2002.
19. Said H.M. Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Annu Rev Physiol 2004; 66:419-46.
20. Stevens C.E., Hume I.D. Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients. Physiol Rev 78:393, 1998.
21. Topping D.L., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81:1031, 2001.

1. Berkes J., Viswanathan V.K., Savkovic S.D., Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52:439, 2003.
2. Blaser M.J., Atherton J.C. Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321, 2004.
3. Dierkes J., Ebert M, Malfertheiner P., Luley C. Helicobacter pylori infection, vitamin В12 and homocysteine. A review. Dig Dis 21:237, 2003.
4. Egan L.J., Sandborn W.J. Advances in the treatment of Crohn’s disease. Gastroenterology 126:1574, 2004.
5. Elson C.O. Genes, microbes, and T cells—new therapeutic targets in Crohn’s disease. N Engl J Med 346(8):614, 2002.
6. Itzkowitz S.H., Yio X. Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7, 2004.
7. Johnson L.R. Gastrointestinal Physiology, 6th ed. St. Louis: Mosby, 2001.
8. Kapadia C.R. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol 36 (5 Suppl):S29, 2003.
9. Kunzelmann K., Mall M. Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82:245, 2002.
10. Laroux F.S., Pavlick K.P., Wolf R.E., Grisham M.B. Dysregula-tion of intestinal mucosal immunity: implications in inflammatory bowel disease. News Physiol Sci 16:272, 2001.
11. Larson D.W., Pemberton J.H. Current concepts and controversies in surgery for IBD. Gastroenterology 126:1611, 2004.
12. Ming S.C., Goldman H. Pathology of the Gastrointestinal Tract. Baltimore: Williams and Wilkins, 1998.
13. Podolsky D.K. Inflammatory bowel disease. N Engl J Med 347:417, 2002.
14. Puri P., Shinkai T. Pathogenesis of Hirschsprung’s disease and its variants: recent progress. Semin Pediatr Surg 13:18, 2004.
15. Spirt M.J. Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther 26:197, 2004.
16. Suerbaum S., Michetti P. Helicobacter pylori infection. N Engl J Med 347(15):1175, 2002.
17. Wolfe M.M., Lichtenstein D.R., Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340(24): 1888, 1999.
18. Wood J.D. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol 35(1 Suppl):Sll, 2002.
19. Wright E.M., Martin M.G., Turk E. Intestinal absorption in health and disease — sugars. Best Pract Res Clin Gastroenterol 17:943, 2003.

1. Barrett E.J. Insulin’s effect on glucose production: direct or indirect? J Clin Invest 111:434, 2003.
2. Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285:E685, 2003.
3. Ceulemans H., Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol Rev 84:1, 2004.
4. Duchen M.R. Roles of mitochondria in health and disease. Diabetes 53(Suppl 1):S96, 2004.
5. Ferrer J.C., Favre C., Gomis R.R. et al. Control of glycogen deposition. FEBS Lett 546:127, 2003.
6. Gleeson T.T. Post-exercise lactate metabolism: a comparative review of sites, pathways, and regulation. Annu Rev Physiol 58:565, 1996.
7. Gunter T.E., Yule D.I., Gunter K.K. et al. Calcium and mitochondria. FEBS Lett 567:96, 2004.
8. Jackson J.B. Proton translocation by transhydrogenase. FEBS Lett 545:18, 2003.
9. Jiang G., Zhang B.B. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284:E671, 2003.
10. Jungas R.L., Halperin M.L., Brosnan J.T. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev 72:419, 1992.
11. Krebs H.A. The tricarboxylic acid cycle. Harvey Lect 44:165, 1948-1949.
12. Kunji E.R. The role and structure of mitochondrial carriers. FEBS Lett 564:239, 2004.
13. Lam T.K., Carpentier A., Lewis G.F. et al. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284:E863, 2003.
14. Mills D.A., Ferguson-Miller S. Understanding the mechanism of proton movement linked to oxygen reduction in cytochrome c oxidase: lessons from other proteins. FEBS Lett 545:47, 2003.
15. Pilkis S.J., Granner D.K. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54:885, 1992.
16. Roden M., Bernroider E. Hepatic glucose metabolism in humans — its role in health and disease. Best Pract Res Clin Endocrinol Metab 17:365, 2003.
17. Ronquist G., Waldenstrom A. Imbalance of plasma membrane ion leak and pump relationship as a new aetiological basis of certain disease states. J Intern Med 254:517, 2003.
18. Spriet L.L., Watt M.J. Regulatory mechanisms in the interaction between carbohydrate and lipid oxidation during exercise. Acta Physiol Scand 178:443, 2003.
19. Wolfsdorf J.I., Weinstein D.A. Glycogen storage diseases. Rev Endocr Metab Disord 4:95, 2003.

1. Assmann G., Nofer J.R. Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54:321, 2003.
2. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96:11041, 1999.
3. Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 363:1139, 2004.
4. Fielding B.A., Frayn K.N. Lipid metabolism. Curr Opin Lipidol 14:389, 2003.
5. Fromenty B., Robin M.A., Igoudjil A. et al. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 30:121,2004.
6. Gotto A.M. Jr., Brinton E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol 43:717, 2004.
7. Grundy S.M., Brewer H.B. Jr., Cleeman J.I. et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute / American Heart Association conference on scientific issues related to definition. Circulation 109:433, 2004.
8. Haemmerle G., Zimmermann R., Zechner R. Letting lipids go: hormone-sensitive lipase. Curr Opin Lipidol 14:289, 2003.
9. Havel R.J., Hamilton R.L. Hepatic catabolism of remnant lipoproteins: where the action is. Arterioscler Thromb Vase Biol 24:213, 2004.
10. Hilgemann D.W. Getting ready for the decade of the lipids. Annu Rev Physiol 65:697, 2003.
11. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125, 2002.
12. LaRosa J.C., Gotto A.M. Jr. Past, present, and future standards for management of dyslipidemia. Am J Med 116 (Suppl 6A):3S, 2004.
13. Libby P. Inflammation in atherosclerosis. Nature 420:868, 2002.
14. Osterud B., Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev 83:1069, 2003.
15. Rinaldo P., Matern D., Bennett M.J. Fatty acid oxidation disorders. Annu Rev Physiol 64:477, 2002.
16. Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 19:92, 2004.
17. Ruderman N.B., Saha A.K., Kraegen E.W. Malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144:5166, 2003.
18. Schonbeck U., Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109 (21 Suppl 1):II18, 2004.
19. Spriet L.L., Watt M.J. Regulatory mechanisms in the interaction between carbohydrate and lipid oxidation during exercise. Acta Physiol Scand 178:443, 2003.
20. Unger R.H. The physiology of cellular liporegulation. Annu Rev Physiol 65:333, 2003.

1. Altenberg G.A. The engine of ABC proteins. News Physiol Sci 18:191,2003.
2. Caldwell J. Pharmacogenetics and individual variation in the range of amino acid adequacy: the biological aspects. J Nutr 134 (6 Suppl):1600S, 2004.
3. Daniel H. Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66:361, 2004.
4. Deves R., Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78:487, 1998.
5. Fukagawa N.K., Galbraith R.A. Advancing age and other factors influencing the balance between amino acid requirements and toxicity. J Nutr 134 (6 Suppl):1569S, 2004.
6. Jans D.A., Hubner S. Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol Rev 76:651,1996.
7. Kadowaki M., Kanazawa T. Amino acids as regulators of proteolysis. J Nutr 133 (6 Suppl 1):2052S, 2003.
8. Kimball S.R., Jefferson L.S. Regulation of global and specific mRNA translation by oral administration of branched-chain amino acids. Biochem Biophys Res Commun 313:423, 2004.
9. Kuhn C.M. Anabolic steroids. Recent Prog Horm Res 57:411, 2002.
10. Layman D.K., Baum J.I. Dietary protein impact on glycemic control during weight loss. J Nutr 134:968S, 2004.
11. Mann G.E., Yudilevich D.L., Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183, 2003.
12. Meijer A.J. Amino acids as regulators and components of non-proteinogenic pathways. J Nutr 133 (6 Suppl 1):2057S, 2003.
13. Moriwaki H., Miwa Y., Tajika M. et al. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 313:405, 2004.
14. Pencharz P.B., Ball R.O. Amino acid needs for early growth and development. J Nutr 134 (6 Suppl): 1566S, 2004.
15. Prod’homme M., Rieu I., Balage M. et al. Insulin and amino acids both strongly participate to the regulation of protein metabolism. Curr Opin Clin Nutr Metab Care 7:71, 2004.
16. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 6:79, 2003.
17. van de Poll M.C., Soeters P.B., Deutz N.E. et al. Renal metabolism of amino acids: its role in interorgan amino acid exchange. Am J Clin Nutr 79:185, 2004.

1. Alison M.R., Vig Р., Russo F. et al. Hepatic stem cells: from inside and outside the liver? Cell Prolif 37:1, 2004.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346:1221, 2002.
3. Ankoma-Sey V. Hepatic regeneration — revisiting the myth of Prometheus. News Physiol Sci 14:149, 1999.
4. Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285:E685, 2003.
5. Bauer M. Heme oxygenase in liver transplantation: heme catabolism and metabolites in the search of function. Hepatology 38:286, 2003.
6. Black D., Lyman S., Heider T.R., Behrns K.E. Molecular and cellular features of hepatic regeneration. J Surg Res 117:306, 2004.
7. Bonder C.S., Kubes P. The future of GI and liver research: editorial perspectives. II. Modulating leukocyte recruitment to splanchnic organs to reduce inflammation. Am J Physiol Ga-strointest Liver Physiol 284:G729, 2003.
8. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3:51, 2003.
9. Diehl А.М. Nonalcoholic steatosis and steatohepatitis. IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282:G1, 2002.
10. Gines P., Cardenas A., Arroyo V., Rodes J. Management of cirrhosis and ascites. N Engl J Med 350:1646, 2004.
11. Gines P., Guevara M., Arroyo V., Rodes J. Hepatorenal syndrome. Lancet 362:1819, 2003.
12. Iredale J.P. Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ 327:143, 2003.
13. Koniaris L.G., McKillop I.H., Schwartz S.I., Zimmers T.A. Liver regeneration. J Am Coll Surg 197:634, 2003.
14. Li M.K., Crawford J.M. The pathology of cholestasis. Semin Liver Dis 24:21, 2004.
15. Portincasa P., Moschetta A., Mazzone A. et al. Water handling and aquaporins in bile formation: recent advances and research trends. J Hepatol 39:864, 2003.
16. Ramadori G., Saile B. Mesenchymal cells in the liver — one cell type or two? Liver 22:283, 2002.
17. Reichen J. The role of the sinusoidal endothelium in liver function. News Physiol Sci 14:117, 1999.
18. Sands J.M. Mammalian urea transporters. Annu Rev Physiol 65:543, 2003.
19. Schoemaker M.H., Moshage H. Defying death: the hepatocyte’s survival kit. Clin Sci (Lond) 107:13, 2004.
20. Schrier R.W., Gurevich A.K., Cadnapaphornchai M.A. Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis. Semin Nephrol 21:157, 2001.
21. Su G.L. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283:G256, 2002.
22. Trauner M., Boyer J.L. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633, 2003.
23. Wolkoff A.W., Cohen D.E. Bile acid regulation of hepatic physiology. I. Hepatocyte transport of bile acids. Am J Physiol Gastrointest Liver Physiol 284:G175, 2003.

1. Barsh G.S., Schwartz M.W. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 3:589, 2002.
2. Coll A.P., Farooqi I.S., Challis B.G. et al. Proopiomelanocortin and energy balance: insights from human and murine genetics. J Clin Endocrinol Metab 89:2557, 2004.
3. Cowley M.A., Cone R.D., Enriori P. et al. Electrophysiological actions of peripheral hormones on melanocortin neurons. Ann N Y Acad Sci 994:175, 2003.
4. Cowley M.A., Grove K.L. Ghrelin — satisfying a hunger for the mechanism. Endocrinology 145:2604, 2004.
5. Da Silva A.A., Kuo J.J., Hall J.E. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension 43:1312, 2004.
6. Davy K.P., Hall J.E. Obesity and hypertension: two epidemics or one? Am J Physiol Regul Integr Comp Physiol 286:R803, 2004.
7. Druce M.R., Small C.J., Bloom S.R. Gut peptides regulating satiety. Endocrinology 145:2660, 2004.
8. Dutta A., Dutta S.K. Vitamin Е and its role in the prevention of atherosclerosis and carcinogenesis: a review. J Am Coll Nutr 22:258, 2003.
9. Flier J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337, 2004.
10. Fraser P.D., Bramley P.M. The biosynthesis and nutritional uses of carotenoids. Prog Lipid Res 43:228, 2004.
11. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395:763, 1998.
12. Grundy S.M. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 89:2595, 2004.
13. Hall J.E., Henegar J.R., Dwyer T.M. et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 11:41, 2004.
14. Hall J.E., Jones D.W. What can we do about the “epidemic” of obesity. Am J Hypertens 15:657, 2002.
15. Hall J.E., Jones D.W., Kuo J.J. et al. Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 5:386, 2003.
16. Jequier E., Tappy L. Regulation of body weight in humans. Physiol Rev 79:451, 1999.
17. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193, 1998.
18. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548, 2004.
19. Korner J., Aronne L.J. Pharmacological approaches to weight reduction: therapeutic targets. J Clin Endocrinol Metab 89:2616, 2004.
20. Korner J., Leibel R.L:. To eat or not to eat — how the gut talks to the brain. N Engl J Med 349:926, 2003.
21. Kuo J.J., Silva A.A., Hall J.E. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension 41:768, 2003.
22. Lucock M. Is folic acid the ultimate functional food component for disease prevention? BMJ 328:211, 2004.
23. National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda M.D. National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases, 1998.
24. O’Rahilly S., Farooqi I.S., Yeo G.S., Challis B.G. Human obesity — lessons from monogenic disorders. Endocrinology 144:3757, 2003.
25. Powers H.J. Riboflavin (vitamin B2) and health. Am J Clin Nutr 77:1352, 2003.
26. Ravussin E. Cellular sensors of feast and famine. J Clin Invest 109:1537, 2002.
27. Rindi G., Laforenza U. Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med 224:246, 2000.
28. Ross S.A., McCaffery P.J., Drager U.C., De Luca L.M. Retinoids in embryonal development. Physiol Rev 80:1021, 2000.
29. Said H.M. Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Annu Rev Physiol 66:419, 2004.
30. Seeley R., Woods S. Monitoring of stored and available fuel by the CNS: implications for obesity. Nat Rev Neurosci 4:901, 2003.
31. Stanley S., Wynne K., Bloom S. Gastrointestinal satiety signals. III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol 286:G693, 2004.
32. Wisse B.E., Schwartz M.W., Cummings D.E. Melanocortin signaling and anorexia in chronic disease states. Ann N Y Acad Sci 994:275, 2003.
33. Woods S.C. Gastrointestinal satiety signals. I. An overview of gastrointestinal signals that influence food intake. Am J Physiol Gastrointest Liver Physiol 286:G7, 2004.
34. Wynne K., Stanley S., Bloom S. The gut and regulation of body weight. J Clin Endocrinol Metab 89:2576, 2004.

1. Argyropoulos G., Harper М.Е. Uncoupling proteins and thermoregulation. J Appl Physiol 92:2187, 2002.
2. Cannon B., Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 84:277, 2004.
3. Chakravarthy M.V., Booth F.W. Eating, exercise, and «thrifty» genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 96:3, 2004.
4. Evans R.M., Barish G.D., Wang Y.X. PPARs and the complex journey to obesity. Nat Med 10:355, 2004.
5. Levine J.A. Nonexercise activity thermogenesis (NEAT): environment and biology. Am J Physiol Endocrinol Metab 286:E675, 2004.
6. Livingstone M.B., Black A.E. Markers of the validity of reported energy intake. J Nutr 133 (Suppl 3):895S, 2003.
7. Lowell B.B., Bachman E.S. Beta-adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem 278:29385, 2003.
8. Morrison S.F. Central pathways controlling brown adipose tissue thermogenesis. News Physiol Sci 19:67, 2004.
9. National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Bethesda, MD: National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases. 1998.
10. Robidoux J., Martin T.L., Collins S. Beta-adrenergic receptors and regulation of energy expenditure: a family affair. Annu Rev Pharmacol Toxicol 44:297, 2004.
11. Rousset S., Alves-Guerra M.C., Mozo J. et al. The biology of mitochondrial uncoupling proteins. Diabetes 53 (Suppl 1):S130, 2004.
12. Seals D.R., Bell C. Chronic sympathetic activation: consequence and cause of age-associated obesity? Diabetes 53:276, 2004.
13. Silva J.E. The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 139:205, 2003.
14. Van Marken Lichtenbelt W.D., Daanen H.A. Cold-induced metabolism. Curr Opin Clin Nutr Metab Care 6:469, 2003.
15. Westerterp K.R. Impacts of vigorous and non-vigorous activity on daily energy expenditure. Proc Nutr Soc 62:645, 2003.
16. Westerterp K.R. Limits to sustainable human metabolic rate. J Exp Biol 204:3183, 2001.
17. Wilson M.M., Morley J.E. Aging and energy balance. J Appl Physiol 95:1728, 2003.
18. Winder W.W. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 91:1017, 2001.
19. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097, 2001.

1. Aronoff D.M., Neilson E.G. Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med 111:304, 2001.
2. Blatteis C.M., Li S., Li Z. et al. Signaling the brain in systemic inflammation: the role of complement. Front Biosci 9:915, 2004.
3. Boulant J.A. Hypothalamic neurons. Mechanisms of sensitivity to temperature. Ann N Y Acad Sci 856:108, 1998.
4. Conti B., Tabarean I., Andrei C., Bartfai T. Cytokines and fever. Front Biosci 9:1433, 2004.
5. Florez-Duquet M., McDonald R.B. Cold-induced thermoregulation and biological aging. Physiol Rev 78:339, 1998.
6. Gourine A.V., Dale N., Gourine V.N., Spyer K.M. Fever in systemic inflammation: roles of purines. Front Biosci 9:1011, 2004.
7. Hildebrand F., Giannoudis P.V., van Griensven M. et al. Pathophysiologic changes and effects of hypothermia on outcome in elective surgery and trauma patients. Am J Surg 187:363, 2004.
8. Ivanov A.I., Romanovsky A.A. Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front Biosci 9:1977, 2004.
9. Katschinski D.M. On heat and cells and proteins. News Physiol Sci 19:11, 2004.
10. Kenney W.L., Munce T.A. Aging and human temperature regulation. J Appl Physiol 95:2598, 2003.
11. Kozak W., Kluger M.J., Tesfaigzi J. et al. Molecular mechanisms of fever and endogenous antipyresis. Ann N Y Acad Sci 917:121, 2000.
12. Leon L.R. Cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol 92:2648, 2002.
13. McDermott M.F. Genetic clues to understanding periodic fevers, and possible therapies. Trends Mol Med 8:550, 2002.
14. Morrison S.F. Central pathways controlling brown adipose tissue thermogenesis. News Physiol Sci 19:67, 2004.
15. Olsen T.S., Weber U.J., Kammersgaard L.P. Therapeutic hypothermia for acute stroke. Lancet Neurol 2:410, 2003.
16. Patapoutian A., Peier A.M., Story G.M., Viswanath V. Ther-moTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci 4:529, 2003.
17. Roth J., Zeisberger E., Vybiral S., Jansky L. Endogenous antipyretics: neuropeptides and glucocorticoids. Front Biosci 9:816, 2004.
18. Saper C.B. Neurobiological basis of fever. Ann N Y Acad Sci 856:90, 1998.
19. Tatro J.B., Sinha P.S. The central melanocortin system and fever. Ann N Y Acad Sci 994:246, 2003.
20. van Marken Lichtenbelt W.D., Daanen H.A. Cold-induced metabolism. Curr Opin Clin Nutr Metab Care 6:469, 2003.

1. Alberts В., Johnson A., Lewis J. et al. Molecular Biology of the Cell. New York: Garland Science, 2002.
2. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 81:1269, 2001.
3. Clark A.J., Baig A.H., Noon L. et al. Expression, desensitization, and internalization of the ACTH receptor (MC2R). Ann N Y Acad Sci 994:111,2003.
4. Katzmann D.J., Odorizzi G., Emr S.D. Receptor downregula-tion and multivesicular-body sorting. Nat Rev Mol Cell Biol 3:893, 2002.
5. Kelly M.J., Qiu J., Ronnekleiv O.K. Estrogen modulation of G-protein-coupled receptor activation of potassium channels in the central nervous system. Ann N Y Acad Sci 1007:6, 2003.
6. Kuhn M. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on gua-nylyl cyclase-A. Circ Res 93:700, 2003.
7. Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. Williams Textbook of Endocrinolog, 10th ed. Philadelphia: WB Saunders, 2003.
8. Losel R.M., Falkenstein E., Feuring M. et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83:965, 2003.
9. Morris A.J., Malbon C.C. Physiological regulation of G protein-linked signaling. Physiol Rev 79:1373, 1999.
10. Nadal A., Diaz M., Valverde M.A. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol Sci 16:251, 2001.
11. Nagaich A.K., Rayasam G.V., Martinez E.D. et al. Subnuclear trafficking and gene targeting by steroid receptors. Ann N Y Acad Sci 1024:213, 2004.
12. Olson T.S., Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283:R7, 2002.
13. O’Shea J.J., Pesu M., Borie D.C., Changelian P.S. A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat Rev Drug Discov 3:555, 2004.
14. Pires-daSilva A., Sommer R.J. The evolution of signaling pathways in animal development. Nat Rev Genet 4:39, 2003.
15. Privalsky M.L. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315, 2004.
16. Spat A., Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489, 2004.
17. Spiegel A.M., Weinstein L.S. Inherited diseases involving G proteins and G protein-coupled receptors. Annu Rev Med 55:27, 2004.
18. Tasken K., Aandahl E.M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84:137, 2004.
19. Vasudevan N., Ogawa S., Pfaff D. Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev 82:923, 2002.
20. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097, 2001.

1. Antunes-Rodrigues J., de Castro М., Elias L.L. et al. Neuroendocrine control of body fluid metabolism. Physiol Rev 84:169, 2004.
2. Besser G.M., Thorner M.O. Comprehensive Clinical Endocrinology, 3rd ed. Philadelphia: Mosby, Elsevier Science Limited, 2002.
3. Burbach J.P., Luckman S.M., Murphy D., Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 81:1197, 2001.
4. Butler A.A., Le Roith D. Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63:141, 2001.
5. Cummings D.E., Merriam G.R. Growth hormone therapy in adults. Annu Rev Med 54:513, 2003.
6. Dattani M., Preece M. Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment. Lancet 363:1977, 2004.
7. Dunn A.J., Swiergiel A.H., Palamarchouk V. Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress. Ann N Y Acad Sci 1018:25, 2004.
8. Edmondson S.R., Thumiger S.P., Werther G.A., Wraight C.J. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 24:737, 2003.
9. Eugster E.A., Pescovitz O.H. Gigantism. J Clin Endocrinol Me-tab 84:4379, 1999.
10. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523, 2000.
11. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629, 2001.
12. Goldspink G. Age-related muscle loss and progressive dysfunction in mechanosensitive growth factor signaling. Ann N Y Acad Sci 1019:294, 2004.
13. Isley W.L. Growth hormone therapy for adults: not ready for prime time? Ann Intern Med 137:190, 2002.
14. Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. Williams Textbook of Endocrinology, 10th ed. Philadelphia: WB Saunders, 2003.
15. Lohmeier T.E. Neurohypophysial hormones. Am J Physiol Re-gul Integr Comp Physiol 285:R715, 2003.
16. Longo V.D., Finch C.E. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299:1342, 2003.
17. Moenter S.M., Defazio R.A., Straume M., Nunemaker C.S. Steroid regulation of GnRH neurons. Ann N Y Acad Sci 1007:143, 2003.
18. Murray R.D. Adult growth hormone replacement: current understanding. Curr Opin Pharmacol 3:642, 2003.
19. Nielsen S., Frokiaer J., Marples D. et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82:205, 2002.
20. Paisley A.N., Trainer P.J. Medical treatment in acromegaly. Curr Opin Pharmacol 3:672, 2003.
21. Strieker E.M., Sved A.F. Controls of vasopressin secretion and thirst: similarities and dissimilarities in signals. Physiol Behav 77:731, 2002.

1. Besser G.M., Thorner М.О. Comprehensive Clinical Endocrinology, 3rd ed. Philadelphia: Mosby, Elsevier Science, 2002.
2. Burger A.G. Environment and thyroid function. J Clin Endocrinol Metab 89:1526, 2004.
3. Cooper D.S. Hyperthyroidism. Lancet 362:459, 2003.
4. Dayan C.M. Interpretation of thyroid function tests. Lancet 357:619, 2001.
5. De La Vieja A., Dohan O. et al. Molecular analysis of the sodi-um/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80:1083, 2000.
6. Dohan O., De La Vieja A., Paroder V. et al. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48, 2003.
7. Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. Williams Textbook of Endocrinology, 10th ed. Philadelphia: WB Saunders Co, 2003.
8. Marino M., McCluskey R.T. Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 279:C1295, 2000.
9. O’Reilly D.S. Thyroid function tests—time for a reassessment. BMJ 320:1332, 2000.
10. Pearce E.N., Farwell A.P., Braverman L.E. Thyroiditis. N Engl J Med 348:2646, 2003.
11. Roberts C.G., Ladenson P.W. Hypothyroidism. Lancet 363:793, 2004.
12. Silva J.E. The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med 139:205, 2003.
13. Stassi G., De Maria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2:195, 2002.
14. Szkudlinski M.W., Fremont V., Ronin C., Weintraub B.D. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships. Physiol Rev 82:473, 2002.
15. Tomer Y., Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24:694, 2003.
16. Vaidya B., Kendall-Taylor P., Pearce S.H. The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab 87:5385, 2002.
17. Vasudevan N., Ogawa S., Pfaff D. Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev 82:923, 2002.
18. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097, 2001.
19. Zhang J., Lazar M.A. The mechanism of action of thyroid hormones. Annu Rev Physio 62:439, 2000.

1. Arnaldi G., Angeli A., Atkinson А.В., Bertagna X., Cavagnini F., Chrousos G.P., Fava G.A., Findling J.W., Gaillard R.C., Grossman A.B., Kola B., Lacroix A., Mancini T., Mantero F., Newell-Price J., Nieman L.K., Sonino N., Vance M.L., Gius-tina A., Boscaro M. Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593, 2003.
2. Besser G.M., Thorner M.O. Comprehensive Clinical Endocrinology, 3rd ed. Philadelphia: Mosby, Elsevier Science Limited, 2002.
3. Boldyreff B., Wehling M. Aldosterone: refreshing a slow hormone by swift action. News Physiol Sci 19:97, 2004.
4. Boscaro M., Barzon L., Fallo F., Sonino N. Cushing’s syndrome. Lancet 357:783, 2001.
5. Cooper M.S., Stewart P.M. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348:727, 2003.
6. De Bosscher K., Vanden Berghe W., Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappa В or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488, 2003.
7. De Paula R.B., da Silva A.A., Hall J.E. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 43:41, 2004.
8. Farman N., Rafestin-Oblin М.Е. Multiple aspects of mineralocor-ticoid selectivity. Am J Physiol Renal Physiol 280:F181, 2001.
9. Hall J.E., Granger J.P., Smith M.J. Jr., Premen A.J. Role of renal hemodynamics and arterial pressure in aldosterone «escape». Hypertension 6 :1183, 1984.
10. Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. Williams Textbook of Endocrinology, 10th ed. Philadelphia: WB Saunders Co, 2003.
11. Losel R.M., Falkenstein E., Feuring M., Schultz M., Tillmann H.C., Rossol-Haseroth K., Wehling M. Nongenomic steroid action: Controversies, questions, and answers. Physiol Rev 83:965, 2003.
12. New M.I. Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol 211:75, 2003.
13. Oberleithner H. Unorthodox sites and modes of aldosterone action. News Physiol Sci 19:51, 2004.
14. O’Shaughnessy K.M., Karet F.E. Salt handling and hypertension. J Clin Invest 113:1075, 2004.
15. Raff H., Findling J.W. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 138:980, 2003.
16. Sheppard K.E. Nuclear receptors. II. Intestinal corticosteroid receptors. Am J Physiol Gastrointest Liver Physiol 282:G742, 2002.
17. Spat A., Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways Physiol Rev 84:489, 2004.
18. Speiser P.W., White P.C. Congenital adrenal hyperplasia. N Engl J Med 349:776, 2003.
19. Stewart P.M. Adrenal replacement therapy: time for an inward look to the medulla? J Clin Endocrinol Metab 89:3677, 2004.
20. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63:193, 2001.
21. Stockand J.D. New ideas about aldosterone signaling in epithelia. Am J Physiol Renal Physiol 282:F559, 2002.
22. Stowasser M., Gordon R.D. Primary aldosteronism: from genesis to genetics. Trends Endocrinol Metab 14:310, 2003.

1. Barrett E.J. Insulin’s effect on glucose production: direct or indirect? J Clin Invest 111:434, 2003.
2. Barthel A., Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285:E685, 2003.
3. Besser G.M., Thorner M.O. Comprehensive Clinical Endocrinology, 3rd ed. Philadelphia: Mosby, Elsevier Science Limited, 2002.
4. Bryant N.J., Govers R., James D.E. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3:267, 2002.
5. Caumo A., Luzi L. First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287:E371, 2004.
6. DeWitt D.E., Hirsch I.B. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 289:2254, 2003.
7. Dunne M.J., Cosgrove K.E., Shepherd R.M. et al. Hyperinsuli-nism in infancy: from basic science to clinical disease. Physiol Rev 84:239, 2004.
8. Efrat S. Regulation of insulin secretion: insights from engineered beta-cell lines. Ann N Y Acad Sci 1014:88, 2004.
9. Grundy S.M., Brewer H.B. Jr., Cleeman J.I. et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433, 2004.
10. Gurnell M., Savage D.B., Chatterjee V.K., O’Rahilly S. The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation. J Clin Endocrinol Metab 88:2412, 2003.
11. Hall J.E., Summers R.L., Brands M.W. et al. Resistance to the metabolic actions of insulin and its role in hypertension. Am J Hypertens 7:772, 1994.
12. Hattersley A.T. Unlocking the secrets of the pancreatic beta cell: man and mouse provide the key. J Clin Invest 114:314, 2004.
13. Holst J.J., Gromada J. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 287:E199, 2004.
14. Hussain M.A., Theise N.D. Stem-cell therapy for diabetes mellitus. Lancet 364:203, 2004.
15. Kowluru A. Regulatory roles for small G proteins in the pancreatic beta-cell: lessons from models of impaired insulin secretion. Am J Physiol Endocrinol Metab 285:E669, 2003.
16. Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. Williams Textbook of Endocrinology, 10th ed. Philadelphia: WB Saunders Co, 2003.
17. List J.F., Habener J.F. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells. Am J Physiol Endocrinol Metab 286:E875, 2004.
18. Mann G.E., Yudilevich D.L., Sobrevia L. Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183, 2003.
19. Perseghin G., Petersen K., Shulman G.I. Cellular mechanism of insulin resistance: potential links with inflammation. Int J Obes Relat Metab Disord 27(Suppl 3):S6, 2003.
20. Pessin J.E., Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106:165, 2000.
21. Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 19:92, 2004.
22. Saltiel A.R. Putting the brakes on insulin signaling. N Engl J Med 349:2560, 2003.
23. Shi Y., Taylor S.I., Tan S.L., Sonenberg N. When translation meets metabolism: multiple links to diabetes. Endocr Rev 24:91, 2003.
24. Ten S., Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab 89:2526, 2004.
25. Wilson P.W., Grundy S.M. The metabolic syndrome: practical guide to origins and treatment: Part I. Circulation 108:1422, 2003.

1. Altkorn D., Vokes Т. Treatment of postmenopausal osteoporosis. JAMA 285:1415, 2001.
2. Bilezikian J.P., Silverberg S.J. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med 350:1746, 2004. Chen R.A., Goodman W.G. Role of the calcium-sensing receptor in parathyroid gland physiology. Am J Physiol Renal Physiol 286:F1005, 2004.
3. Compston J.E. Sex steroids and bone. Physiol Rev 81:419, 2001. Delmas P.D. Treatment of postmenopausal osteoporosis. Lancet 359:2018, 2002.
4. Goodman W.G., Juppner H., Salusky I.B., Sherrard D.J. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 63:1, 2003. Gurlek A., Pittelkow M.R., Kumar R. Modulation of growth factor/cytokine synthesis and signaling by lalpha,25-dihy-droxyvitamin D(3): implications in cell growth and differentiation. Endocr Rev 23:763, 2002.
5. Hofer A.M., Brown E.M. Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol 4:530, 2003.
6. Larsen P.R., Kronenberg H.M., Melmed S., Polonsky K.S. Williams Textbook of Endocrinology, 10th ed. Philadelphia: WB Saunders Co, 2003.
7. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477, 2001. Marx S.J. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863, 2000.
8. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785, 2001.
9. Peng J.B., Brown E.M., Hediger M.A. Apical entry channels in calcium-transporting epithelia, News Physiol Sci 18:158,2003. Silver J., Kilav R., Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 283:F367,2002. Tordoff M.G. Calcium: taste, intake, and appetite. Physiol Rev 81:1567, 2001.
10. Wharton B., Bishop N. Rickets. Lancet 362:1389, 2003.
11. Woolf A.D., Akesson K. Preventing fractures in elderly people. BMJ 327:89, 2003.

1. Anderson R.A., Baird D.T. Male contraception. Endocr. Rev 23:735, 2002.
2. Barry M.J., Roehrborn C.G. Benign prostatic hyperplasia. BMJ 323:1042, 2001.
3. Brennan J., Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 5:509, 2004.
4. Cajochen C., Krauchi K., Wirz-Justice A. Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 15:432, 2003.
5. Cheng C.Y., Mruk D.D. Cell junction dynamics in the testis: Sertoli-germ cell interactions and male contraceptive development. Physiol Rev 82:825, 2002.
6. Cooke H.J., Saunders P.T. Mouse models of male infertility. Nat Rev Genet 3:790, 2002.
7. De Kretser D.M. Is spermatogenic damage associated with Ley-dig cell dysfunction? J Clin Endocrinol Metab 89:3158, 2004.
8. DeMarzo A.M., Nelson W.G., Isaacs W.B., Epstein J.I. Pathological and molecular aspects of prostate cancer. Lancet 361:955, 2003.
9. Foresta C., Moro E., Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev 22:226, 2001.
10. Heinlein C.A., Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175, 2002.
11. Jobling M.A., Tyler-Smith C. The human Y chromosome: an evolutionary marker comes of age. Nat Rev Genet 4:598, 2003.
12. Kandeel F.R., Koussa V.K., Swerdloff R.S. Male sexual function and its disorders: physiology, pathophysiology, clinical investigation, and treatment. Endocr Rev 22:342, 2001.
13. Lahn B.T., Pearson N.M., Jegalian K. The human Y chromosome, in the light of evolution. Nat Rev Genet 2:207, 2001.
14. Lanfranco F., Kamischke A., Zitzmann M., Nieschlag E. Klinefelter’s syndrome. Lancet 364:273, 2004.
15. Liu P.Y., Death A.K., Handelsman D.J. Androgens and cardiovascular disease. Endocr. Rev 24:313, 2003.
16. Nelson P.S., Montgomery B. Unconventional therapy for prostate cancer: good, bad or questionable? Nat Rev Cancer 3:845, 2003.
17. Nelson W.G., De Marzo A.M., Isaacs W.B. Prostate cancer. N Engl J Med 349:366, 2003.
18. O’Donnell L., Robertson K.M., Jones M.E., Simpson E.R. Estrogen and spermatogenesis. Endocr. Rev 22:289, 2001.
19. Plant T.M., Marshall G.R. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr. Rev 22:764, 2001.
20. Reckelhoff J.F. Gender differences in the regulation of blood pressure. Hypertension 37:1199, 2001.
21. Rhoden E.L., Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 350:482, 2004.
22. Riggs B.L., Khosla S., Melton L.J. 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev 23:279, 2002.
23. Shabsigh R., Anastasiadis A.G. Erectile dysfunction. Annu. Rev. Med 54:153, 2003.
24. Simonneaux V., Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 55:325, 2003.

1. Altkorn D., Vokes Т. Treatment of postmenopausal osteoporosis. JAMA 285:1415, 2001.
2. Bastian L.A., Smith C.M., Nanda K. Is this woman perimeno-pausal? JAMA 289:895, 2003.
3. Beral V., Banks E., Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 360:942, 2002.
4. Compston J.E. Sex steroids and bone. Physiol Rev 81:419, 2001.
5. Gruber C.J., Tschugguel W., Schneeberger C., Huber J.C. Production and actions of estrogens. N Engl J Med 346:340,2002.
6. Hamilton-Fairley D., Taylor A. Anovulation. BMJ 327:546, 2003.
7. Lorenzo J. A new hypothesis for how sex steroid hormones regulate bone mass. J Clin Invest 111:1641, 2003.
8. Manson J.E., Martin K.A. Postmenopausal hormone-replacement therapy. N Engl J Med 345:34, 2001.
9. Nadal A., Diaz M., Valverde M.A. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol Sci 16:251, 2001.
10. Nelson H.D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291:1610, 2004.
11. Nilsson S., Makela S., Treuter E. et al. Mechanisms of estrogen action. Physiol Rev 81:1535, 2001.
12. Niswender G.D., Juengel J.L., Silva P.J. et al. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 80:1, 2000.
13. Petitti D.B. Combination estrogen-progestin oral contraceptives. N Engl J Med 349:1443, 2003.
14. Pettersson K., Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 63:165, 2001.
15. Riggs B.L. The mechanisms of estrogen regulation of bone resorption. J Clin Invest 106:1203, 2000.
16. Riggs B.L., Hartmann L.C. Selective estrogen-receptor modulators — mechanisms of action and application to clinical practice. N Engl J Med 348:618, 2003.
17. Smith S., Pfeifer S.M., Collins J.A. Diagnosis and management of female infertility. JAMA 290:1767, 2003.
18. Terasawa E., Fernandez D.L. Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 22:111, 2001.
19. Toran-Allerand C.D. A plethora of estrogen receptors in the brain: where will it end? Endocrinology 145:1069, 2004.
20. Van der Eerden B.C., Karperien M., Wit J.M. Systemic and local regulation of the growth plate. Endocr Rev 24:782, 2003.
21. Vasudevan N., Ogawa S., Pfaff D. Estrogen and thyroid hormone receptor interactions: physiological flexibility by molecular specificity. Physiol Rev 82:923, 2002.

1. Alexander В.Т., Bennett W.A., Khalil R.A., Granger J.P. Preeclampsia: linking placental ischemia with cardiovascular-renal dysfunction. News Physiol Sci 16:282, 2001.
2. Ben-Jonathan N., Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724, 2001.
3. Casey M.L., MacDonald P.C. The endocrinology of human parturition. Ann N Y Acad Sci 828:273, 1997.
4. Challis J.R., Lye S.J., Gibb W. et al. Understanding preterm labor. Ann N Y Acad Sci 943:225, 2001.
5. Cross J.C., Simmons D.G., Watson E.D. Chorioallantoic morphogenesis and formation of the placental villous tree. Ann N Y Acad Sci 995:84, 2003.
6. Davison J.M., Homuth V., Jeyabalan A. et al. New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol 15:2440, 2004.
7. Dekker G., Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 357:209, 2001.
8. Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523, 2000.
9. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629, 2001.
10. Goff in V., Binart N., Touraine P., Kelly P.A. Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47, 2002.
11. Hall J.G. Twinning. Lancet 362:735, 2003.
12. Kanaka-Gantenbein C., Mastorakos G., Chrousos G.P. Endocrine-related causes and consequences of intrauterine growth retardation. Ann N Y Acad Sci 997:150, 2003.
13. Khalaf Y. ABC of subfertility: tubal subfertility. BMJ 327:610, 2003.
14. Khalil R.A., Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283:R29, 2002.
15. Labbok M.H., Clark D., Goldman A.S. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol 4:565, 2004.
16. MacLaughlin D.T., Donahoe P.K. Sex determination and differentiation. N Engl J Med 350:367, 2004.
17. Mastorakos G., Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 997:136, 2003.
18. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2:656, 2002.
19. Roberts J.M., Cooper D.W. Pathogenesis and genetics of preeclampsia. Lancet 357:53, 2001.
20. Roberts J.M., Pearson G., Cutler J. Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 41:437, 2003.
21. Wu G., Bazer F.W., Cudd T.A. et al. Maternal nutrition and fetal development. J Nutr 134:2169, 2004.

1. Bissonnette J.M. Mechanisms regulating hypoxic respiratory depression during fetal and postnatal life. Am J Physiol Regul Integr Comp Physiol 278:R1391, 2000.
2. Challis J.R.G., Matthews S.G., Gibb W., Lye S.J. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 21:514, 2000.
3. Chen Y., Lasaitiene D., Friberg P. The renin-angiotensin system in kidney development. Acta Physiol Scand 181:529, 2004.
4. De Castro F. Chemotropic molecules: guides for axonal pathfinding and cell migration during CNS development. News Physiol Sci 18:130, 2003.
5. Dunne M.J., Cosgrove K.E., Shepherd R.M. et al. Hyperinsuli-nism in infancy: from basic science to clinical disease. Physiol Rev 84:239, 2004.
6. Hilaire G., Duron B. Maturation of the mammalian respiratory system. Physiol Rev 79:325, 1999.
7. Holemans K., Aerts L., Van Assche F.A. Lifetime consequences of abnormal fetal pancreatic development. J Physiol 547:11, 2003.
8. Jensen B.L., Stubbe J., Madsen K. et al. The renin-angiotensin system in kidney development: role of COX-2 and adrenal steroids. Actl Physiol Scand 181:549, 2004.
9. Johnson M.H. Functional brain development in humans. Nat Rev Neurosci 2:475, 2001.
10. Kanwar Y.S., Wada J., Lin S., Danesh F.R. et al. Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis. Am J Physiol Renal Physiol 286:F202, 2004.
11. Kovacs C.S., Kronenberg H.M. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18:832, 1997.
12. Labbok M.H., Clark D., Goldman A.S. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol 4:565, 2004.
13. MacLellan W.R., Schneider M.D. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol 62:289, 2000.
14. Matias A., Montenegro N., Areias J.C., Leite L.P. Haemodynamic evaluation of the first trimester fetus with special emphasis on venous return. Hum Reprod Update 6:177, 2000.
15. McMurtry I.F. Pre- and postnatal lung development, maturation, and plasticity. Am J Physiol Lung Cell Mol Physiol 282:L341, 2002.
16. Olver R.E., Walters D.V., Wilson M.S. Developmental regulation of lung liquid transport. Annu Rev Physiol 66:77, 2004.
17. Ross M.G., Nijland M.J. Development of ingestive behavior. Am J Physiol 274:R879, 1998.
18. Shannon J.M., Hyatt B.A. Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol 66:625, 2004.
19. Srivastava D. Genetic assembly of the heart: implications for congenital heart disease. Annu Rev Physiol 63:451, 2001.
20. Wood C.E., Tong H. Central nervous system regulation of reflex responses to hypotension during fetal life. Am J Physiol 277:R1541, 1999.

1. Blair S.N., LaMonte M.J., Nichaman M.Z. The evolution of physical activity recommendations. How much is enough? Am J Clin Nutr 79:913S, 2004.
2. Booth F.W., Chakravarthy M.V., Spangenburg E.E. Exercise and gene expression: physiological regulation of the human genome through physical activity. J Physiol 543:399, 2002.
3. Chakravarthy M.V., Booth F.W. Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol 96:3, 2004.
4. Clausen T. Effects of age and exercise training on NA+K+-pumps in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 285:R720, 2003.
5. Delp M.D., Laughlin M.H. Regulation of skeletal muscle perfusion during exercise. Acta Physiol Scand 162:411, 1998.
6. Evans N.A. Current concepts in anabolic-androgenic steroids. Am J Sports Med 32:534, 2004.
7. Gandevia S.C. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 81:1725, 2001.
8. Glass J.D. Signalling pathways that mediate skeletal muscle hypertrophy and atropy. Nat Cell Biol 5:87, 2003.
9. Guyton A.C., Jones C.E., Coleman T.B. Circulatory Physiology: Cardiac Output and Its Regulation, 2nd ed. Philadelphia: WB Saunders Co, 1973.
10. Hochachka P.W., Beatty C.L., Burelle Y. et al. The lactate paradox in human high-altitude physiological performance. News Physiol Sci 17:122, 2002.
11. Johnson N.A., Stannard S.R., Thompson M.W. Muscle triglyceride and glycogen in endurance exercise: implications for performance. Sports Med 34:51, 2004.
12. Kraemer W.J., Adams K., Cafarelli E. et al. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34:364, 2002.
13. Myburgh K.H. What makes an endurance athlete world-class? Not simply a physiological conundrum. Comp Biochem Physiol A Mol Integr Physiol 136:171, 2003.
14. Noakes T.D., Peltonen J.E., Rusko H.K. Evidence that a central governor regulates exercise performance during acute hypoxia and hyperoxia. J Exp Biol 204:3225, 2001.
15. Rennie M.J., Wackerhage H., Spangenburg E.E., Booth F.W. Control of the size of the human muscle mass. Annu Rev Physiol 66:799, 2004.
16. Schnermann J. Exercise. Am J Physiol Regul Integr Comp Physiol 283:R2, 2002.
17. Spangenburg E.E., Booth F.W. Molecular regulation of individual skeletal muscle fibre types. Acta Physiol Scand 178:413,2003.
18. Steele D.S., Duke A.M. Metabolic factors contributing to altered Ca2+ regulation in skeletal muscle fatigue. Acta Physiol Scand 179:39, 2003.
19. Tanaka H., Seals D.R. Dynamic exercise performance in Masters athletes: insight into the effects of primary human aging on physiological functional capacity. J Appl Physiol 95:2152, 2003.
20. Tschakovsky M.E., Hughson R.L. Interaction of factors determining oxygen uptake at the onset of exercise. J Appl Physiol 86:1101, 1999.
21. Watt M.J., Heigenhauser G.J., Spriet L.L. Intramuscular triacyl-glycerol utilization in human skeletal muscle during exercise: is there a controversy? J Appl Physiol 93:1185, 2002.

- Вернуться в оглавление раздела "Физиология человека."

Редактор: Искандер Милевски. Дата обновления публикации: 28.12.2020